{"docstore/metadata": {"d863d433-4475-4344-b4ac-5ac34a833ccd": {"doc_hash": "e38d1494703f6d2eef7ca41d10ba0a0662daa4672915973194f41d92e4ef237e"}, "aba4136e-5beb-4831-9277-1f1b51256d0b": {"doc_hash": "e45b6fc9c297694941ae987bbf1be20db0fbee1b33d7acf218a2f3f8a6363863"}, "5d5d60e5-7647-43b4-a9b9-c8b07b310041": {"doc_hash": "48a1510bdcd903f8f0298c41cf2f3c0e0473c3b9f3add60301056f56afa89393"}, "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0": {"doc_hash": "b6ba3113f39dd46081bef25a64d546cd04abd036c0319ff812982f7bd7f6957c"}, "ea199b63-3470-44b2-ac1a-0efb10f163e0": {"doc_hash": "c3cc8745a2baf79897ea02c220ddf5e99955b65e7fc4bafb1e0ed82a2c9a6497"}, "3912338c-7bfe-4182-b003-f8473c2f2a85": {"doc_hash": "842d81a39966dc9bac383c7e6a2226ef7bdc3001279b796df62f1e2072e91e73"}, "1d790fc5-cbe7-43bf-86be-154656ecfdd0": {"doc_hash": "f322594c097aecf851a7aff72c424496469c20218f926085bb1dce907fb04bbe"}, "2505f607-76f0-4004-8664-416ab7fb3d81": {"doc_hash": "01112e9101fc6f783e62184674665bb021dd3c30df63feb8cd0a783fe33c7214", "ref_doc_id": "d863d433-4475-4344-b4ac-5ac34a833ccd"}, "6e366ac5-3820-4023-a3b3-aee173a5b55c": {"doc_hash": "8efce36d8cab340249e73661e157019cafd1fb7137410c93657a71addef99809", "ref_doc_id": "d863d433-4475-4344-b4ac-5ac34a833ccd"}, "b120fde4-fa4f-4c97-af04-9fde0fb3029e": {"doc_hash": "94571cc97b30a594b461dcc6fd8f93bfdb87cf43fa608b67f331a72c305a1552", "ref_doc_id": "d863d433-4475-4344-b4ac-5ac34a833ccd"}, "2f6ea9d5-0962-45c2-be7e-4881854399e7": {"doc_hash": "104cefd7f5b46709d80418c1606b5094c4abd9234efc99c7302f99b4f15421bf", "ref_doc_id": "d863d433-4475-4344-b4ac-5ac34a833ccd"}, "d5635ba9-db72-4c20-b5f1-824b6d9e30c4": {"doc_hash": "3507afa0472944ca39f43eee3e228b22e68099de4881d28d025d45ebcf46d911", "ref_doc_id": "d863d433-4475-4344-b4ac-5ac34a833ccd"}, "f2600675-2532-4c69-9b9b-9c26cf11d7b4": {"doc_hash": "24509a791f987238b30c13f84f0f321c225e51cd42406b806bf33327cb8384ba", "ref_doc_id": "d863d433-4475-4344-b4ac-5ac34a833ccd"}, "8622325b-3b85-44ae-b3c3-d19486fd274b": {"doc_hash": "db0fa6eb50cedc2f4cdada7415edfa8b0fb9fc30ba5b9a89a64f2b742f1b8b25", "ref_doc_id": "d863d433-4475-4344-b4ac-5ac34a833ccd"}, "b0695074-4415-46d5-84c3-dcb05ef29450": {"doc_hash": "863559daf7d5cb877a68fa98e372e0b8368184218f3ecc59a6901e73a9c98a6a", "ref_doc_id": "aba4136e-5beb-4831-9277-1f1b51256d0b"}, "4295b39f-da86-44b8-8706-535df9e144ec": {"doc_hash": "521fa80ffda5ce03d3edb42fa61c160b2e2e6b30c0b3dad7a74198de8f46c6a6", "ref_doc_id": "aba4136e-5beb-4831-9277-1f1b51256d0b"}, "86d9261a-1a83-4d8b-a789-8a20946a14e1": {"doc_hash": "24676310f313108c88b0a238184c2e2da4f43da78f671d204ae784fb826f323d", "ref_doc_id": "aba4136e-5beb-4831-9277-1f1b51256d0b"}, "cc9d669f-c47b-4262-ba30-9ada3e4dd36f": {"doc_hash": "0bb510d39d1050414ebfabfc7c5b3bc8e4047b07822c48ebbd2f7c6757e60ca2", "ref_doc_id": "aba4136e-5beb-4831-9277-1f1b51256d0b"}, "099c6047-9593-4c6d-a8b8-8cdaf39dfb5e": {"doc_hash": "6ec9d6e2ec0194a712101f2c419ccdb6b7ac9ee7d988fa24f9d592b161ad1a8b", "ref_doc_id": "aba4136e-5beb-4831-9277-1f1b51256d0b"}, "84761669-4bc7-43e7-9437-cec149f174f4": {"doc_hash": "232ba7e0d9b36d6bad3cd39b3d81d5d11aadf5c5b536e903911edf13ee7a20e2", "ref_doc_id": "aba4136e-5beb-4831-9277-1f1b51256d0b"}, "f3f06a58-5cd3-4e27-a2de-3ddd2271cdb2": {"doc_hash": "55b36fa5684b92a8931d7e73782f52c83fbf2c914b845fc2cbf04f50b96ee212", "ref_doc_id": "aba4136e-5beb-4831-9277-1f1b51256d0b"}, "e47539c1-5d52-41f9-a080-87dc906ae48c": {"doc_hash": "fef13ff84e06fbd336fab4c7eff69ac5efdc3e7b2495bb3f83f3970e8cca41f3", "ref_doc_id": "aba4136e-5beb-4831-9277-1f1b51256d0b"}, "1c2c7974-211c-4589-9eb0-0d127d403dfd": {"doc_hash": "b8b9c89fd9530bbb8f11f307ae17482b9ed9c6cd8509a0b082291c36c432ff64", "ref_doc_id": "aba4136e-5beb-4831-9277-1f1b51256d0b"}, "110a19ca-a76e-4592-9f8c-1c67d9f59b6f": {"doc_hash": "393b67619b53a859d12942c1bf33a9ec1d70d6c24029fb21f20648ba0c1d4450", "ref_doc_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041"}, "26fcb611-28f0-4c25-96a4-9b7c996e19f6": {"doc_hash": "099c27634dbe8ec1bb3999c0f751d523865b20f117d294bd00ed0fe87321b2b3", "ref_doc_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041"}, "3b96abaa-2b8c-4b15-90c9-084c6f9a0349": {"doc_hash": "d5a9b14dad2406f9e51ff72c57c39f35ffc9732916914ecb777ef878eca27113", "ref_doc_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041"}, "2debd2bb-cf88-4ec6-b474-b80bf2e51b68": {"doc_hash": "34efbfab860e1e116b70225afe470ef46c6719cdb6e819d72accdfe1397c9fdb", "ref_doc_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041"}, "f4e4bcfd-bff0-4631-b96a-da8d95688275": {"doc_hash": "45ec0f85d1677f5093176ee5f52cfb69f07ac88e13ef6ed8a8f31e9b99742b76", "ref_doc_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041"}, "6b9cd269-5e33-4c9b-8931-caf3f76b1f52": {"doc_hash": "800daf37937fe0a4c299f5cfd9fc43feb86d5ad97d97375bb113edd40027d9f7", "ref_doc_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041"}, "860d1f00-25d1-4acb-b7c1-f5f6f880562e": {"doc_hash": "35161aa9fcd1acfacd7900faaac66aa7a7f0a46ddaff2d1478abaad88edc8cce", "ref_doc_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041"}, "294390df-0ea7-40aa-936c-717e6d1ff2b9": {"doc_hash": "befeec8d79f694a9a3168beb5eebcd55ba8b045d0f686114ac34b139fd64731a", "ref_doc_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041"}, "45530c7f-a444-43f8-b4c9-21184fd315d5": {"doc_hash": "6fba20aa7d7d304b0162d0d87e4891783d8c1a3ee4301f6719bf4b2d6b84b531", "ref_doc_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041"}, "1404f48b-f50c-4e2c-87b3-bd7e8ec8f3ab": {"doc_hash": "52078e02062341e3ae21890d8767f206cb9dff8a069963ce2958fbaa282cf35f", "ref_doc_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041"}, "ed749120-b03f-46b2-b747-55f47aaac973": {"doc_hash": "579409972f058a287d01bf53eae91aae57566a9444a3d92374c7712cb091f04e", "ref_doc_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0"}, "8e86ca9e-3616-4894-85cc-25e31416452a": {"doc_hash": "a40b3bdd22d423907f324e8c4e5f0554f9b57e0e7d2b9dc5fa7a83ce5f0c7564", "ref_doc_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0"}, "15859d1f-cf7e-42f7-a393-c4df7088ff4c": {"doc_hash": "0a7f08027c467ca0abc1784e3db6701a7379c094f3cd9291012e9be79c6affec", "ref_doc_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0"}, "a14a78f8-9f82-42dd-88ee-65b6feca9b87": {"doc_hash": "d004e279386235c33ac1a2d4d184f49a37eb77d8c71b98d92ac9f66d504fcb2a", "ref_doc_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0"}, "64bd04da-df4c-4973-94cd-c7fcaeedb714": {"doc_hash": "cb4ab3faf405fb0d2b0616af8b7deafe11067a342b1f8f9646832f31b85ab205", "ref_doc_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0"}, "69f8d83e-18b3-4607-8420-f11c9e6f697b": {"doc_hash": "09583e29f4c90c53f1334cb8322024d5908e4054d4019c71e1002cd15f393bc4", "ref_doc_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0"}, "520dfa32-0f3a-4110-a50c-f282d9cc1c23": {"doc_hash": "4ca2e19c735c64d900f26a29feb1a4a89773151a600739a57709a5d941bb5e6d", "ref_doc_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0"}, "59eb8509-419c-48ea-ac83-2cc819e8df25": {"doc_hash": "9d5db7fdbf2c231fb80447ebb8116ef8094616b755ad96721ea7413699c36da6", "ref_doc_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0"}, "23bb07db-3dc6-44fe-ba08-7f280da80532": {"doc_hash": "048f6e1c328ce2b3178da999cd1f41557b30fbcffb8fd5c02d04224844689603", "ref_doc_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0"}, "a35ab5ca-cb22-4893-87e6-9ceaf1a21ef0": {"doc_hash": "cf350e74e89b4b863345369c43738fd06c53910e75fff4f7f38526a8820e7cbd", "ref_doc_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0"}, "46fdc0f7-bbda-4ee5-bdb9-f0dd2e4fef86": {"doc_hash": "469c65a8f0d60f289aa5b1592c9845d81dd20038056eb7040ab305f1048182a3", "ref_doc_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0"}, "cc893d8c-ea56-4c2e-bfd7-44163d19a56f": {"doc_hash": "ff05cf7009a683deeebecf647700fe1c430f7c5269c8998df6cd72981214bdb1", "ref_doc_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0"}, "d84b3478-90f6-473a-ba87-d79c2c6d1f28": {"doc_hash": "ed86fedc18280f7bf20a35f75d9839ed84f21bca78b3d1965a3ad2af881d6216", "ref_doc_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0"}, "da72eb85-5958-4c85-bb21-003423e68378": {"doc_hash": "6859950de7ce4f1b9aeac885534c51dd42144692b96c20902b6d0404f8a84ca4", "ref_doc_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0"}, "8a78a7de-fc0e-46e5-bc3c-26a619c700a1": {"doc_hash": "ee1adda328b2d6413428c0b38d77567a32c861c8acb7fd17b17fe26f7512af36", "ref_doc_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0"}, "a32bb617-616d-4900-bc75-90ce1ff77546": {"doc_hash": "26f265e618a9edb3f8a03f58536c5a45708dee5b5f0b786caf3fa8b7806c8363", "ref_doc_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0"}, "46381ef6-bf54-4f70-b983-21cd466c021f": {"doc_hash": "551a70bf497372282b8e7edd5bcf02ec87c6d8dfffd9431da0e9d9d8fc6201b3", "ref_doc_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0"}, "ac84563f-2d04-4318-8d04-08658385cefc": {"doc_hash": "2cc38174f4c100f49b15cbdd3e41f387a5c8a2d75f1515035c67e9adb1215782", "ref_doc_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0"}, "2e4a3692-d6d6-4d4e-80ea-7761ab80756e": {"doc_hash": "eaeb018d9aa00204053f149e06abec253685625ae41360264cca4fde4ff1797e", "ref_doc_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0"}, "46bb668f-3a1f-4e5d-b6ad-6be40de3b4f1": {"doc_hash": "fcd604c104f6973a9bbc1dfc0b86cf55c1157d4217970009d91e27d71165636c", "ref_doc_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0"}, "048546fa-55b9-43b2-ba78-cb525e86a123": {"doc_hash": "cc93e686f5139eb5d665763a09f5ae9667591e130e5a15b836b580d9bca2d629", "ref_doc_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0"}, "e434d935-f7b1-477e-aaa4-c3e3ec17e050": {"doc_hash": "f089a2c787c7d7d1b5d5f70dc0f58df0e9f1f1a7f8028d18d6b198f2b51120d6", "ref_doc_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0"}, "6320e6a3-0d3b-46f8-b318-3d2e11911304": {"doc_hash": "4466fe7bfe5d338d3e769e1e6bdf43afbd3f76fa41b52f1cc056997214c3f645", "ref_doc_id": "3912338c-7bfe-4182-b003-f8473c2f2a85"}, "404bd5dd-4f3a-41f8-9d7a-ca0352f47cff": {"doc_hash": "c91dad695c6b17776b6ff34cdcfd48dfc1aca640e0bfbb4388859646ca751d37", "ref_doc_id": "3912338c-7bfe-4182-b003-f8473c2f2a85"}, "2163d6f1-8ced-4c37-9df7-3d4f7d627e72": {"doc_hash": "adeebb14662b13b6a1cc198b99b2bd6c35e04c961e6ad3b7695e31cfe322f825", "ref_doc_id": "3912338c-7bfe-4182-b003-f8473c2f2a85"}, "599f1eae-1f3f-4a0b-9bd7-597c74c5119c": {"doc_hash": "932171ca1d49894e826063f7dca1721992b3c2ae76d3206ed0989f47fdc94bc3", "ref_doc_id": "3912338c-7bfe-4182-b003-f8473c2f2a85"}, "3e7e5606-daf7-4b33-b882-064069d55310": {"doc_hash": "ca2608cd19132647333d62bf507698f5527d06faf567a931b9aa91e7a5cd8458", "ref_doc_id": "3912338c-7bfe-4182-b003-f8473c2f2a85"}, "29513cc1-75b6-4d7f-a799-adfe1ae3a184": {"doc_hash": "14afff071e5af24bdd9195e6b42c709fff817aa0eab9b899c74f3734735eb860", "ref_doc_id": "3912338c-7bfe-4182-b003-f8473c2f2a85"}, "ce35d324-3fb3-4754-9e1a-393c0cb9e598": {"doc_hash": "e5cc81ca1449630a76ac6d8e99750b1d819db0fd6f409ee0da7e252f5c8089bd", "ref_doc_id": "3912338c-7bfe-4182-b003-f8473c2f2a85"}, "109d7ca1-ca8c-4723-97e3-2a22adc25609": {"doc_hash": "4aefb09bad423046c467de5711bbb60bc3be2de990661db00f3da3bd14672937", "ref_doc_id": "3912338c-7bfe-4182-b003-f8473c2f2a85"}, "476c4ccf-ab5b-4360-aa16-57090bfd2fae": {"doc_hash": "2be8cf28dd4c6b014847d3e3cf04f78a0eb2cac03394ffb7f661d6a5f15214df", "ref_doc_id": "3912338c-7bfe-4182-b003-f8473c2f2a85"}, "68c6d0d0-321a-47cd-b116-d6e9bb7f2099": {"doc_hash": "9725f022fdf5d7f5881c7733a6f463bf36e4522aac1f39fed2b15b83adee337c", "ref_doc_id": "3912338c-7bfe-4182-b003-f8473c2f2a85"}, "a5e7e202-0b81-4407-b386-6bd1103ea194": {"doc_hash": "0e4d72fc82be473392b950aca6a49c13aeb0b121e2558c0e704337dd4517bb24", "ref_doc_id": "3912338c-7bfe-4182-b003-f8473c2f2a85"}, "0ae7646f-cd8d-46a1-ba06-97484cab2906": {"doc_hash": "37439ce32dd122e859a1613d18a2157b4c67dd02fc5d49f8f92d4cdefac68078", "ref_doc_id": "3912338c-7bfe-4182-b003-f8473c2f2a85"}, "8d5243d6-4bc1-4fb3-a94b-85d8bbb0151b": {"doc_hash": "907d342c621d12b1d44b6ef15cfe31cefafb99f44c3868b50bc29d909fa9e1df", "ref_doc_id": "3912338c-7bfe-4182-b003-f8473c2f2a85"}, "c1440b50-82c9-45c0-a93a-1720f15f3e4d": {"doc_hash": "a4eef29da8339997ef3383f74fbd204c93147ae506fd518d804c023e3e4b014e", "ref_doc_id": "3912338c-7bfe-4182-b003-f8473c2f2a85"}, "5c8cbb78-2042-465c-a1cf-81e82ab1a66b": {"doc_hash": "8cc562f39cd9a5886aa1464cba77f483f11025cb0191e0394f20ba5df4987f15", "ref_doc_id": "1d790fc5-cbe7-43bf-86be-154656ecfdd0"}, "5c9ed7c6-da9b-4d16-b4be-dd46988a622d": {"doc_hash": "d63592245c30426b4b8445921beaed4ab9be30aeefa3314c8ae0f737ca78a95a", "ref_doc_id": "1d790fc5-cbe7-43bf-86be-154656ecfdd0"}, "fed5c235-73aa-4421-8572-55071b4740a0": {"doc_hash": "f11ee1497d9fd1d4c323b0e82f5b7492589c3de21452baf95c7d6f4de1f76294", "ref_doc_id": "1d790fc5-cbe7-43bf-86be-154656ecfdd0"}}, "docstore/data": {"2505f607-76f0-4004-8664-416ab7fb3d81": {"__data__": {"id_": "2505f607-76f0-4004-8664-416ab7fb3d81", "embedding": null, "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "d863d433-4475-4344-b4ac-5ac34a833ccd", "node_type": "4", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e38d1494703f6d2eef7ca41d10ba0a0662daa4672915973194f41d92e4ef237e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6e366ac5-3820-4023-a3b3-aee173a5b55c", "node_type": "1", "metadata": {}, "hash": "7f05335316059b16da14218afc92db12a5b07f5dd0f53c102823f12929472ecc", "class_name": "RelatedNodeInfo"}}, "text": "PEDIATRIC PHARMACOLOGY \nAND THERAPEUTICS PaulS. Lietman, Editor \nProspective comparative trial of moxalactam \nversus ampicillin or chloramph.enicol for treatment \nof Haemophilus influenzae type b meningitis \nin children \nIn a prospective, randomized study, moxalactam in 44 children was cooipared with ampicillin or \nchloramphenicol in 47 children for the treatment of 1taemophilus influenzae type b meningitis. Both \ngroups were comparable in terms of clinical and laboratory findings at admission. The hospital \ncourse, neurologic sequelae including deafness, and number of deaths were the same for both groups.", "start_char_idx": 0, "end_char_idx": 613, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6e366ac5-3820-4023-a3b3-aee173a5b55c": {"__data__": {"id_": "6e366ac5-3820-4023-a3b3-aee173a5b55c", "embedding": null, "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "d863d433-4475-4344-b4ac-5ac34a833ccd", "node_type": "4", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e38d1494703f6d2eef7ca41d10ba0a0662daa4672915973194f41d92e4ef237e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2505f607-76f0-4004-8664-416ab7fb3d81", "node_type": "1", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "01112e9101fc6f783e62184674665bb021dd3c30df63feb8cd0a783fe33c7214", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b120fde4-fa4f-4c97-af04-9fde0fb3029e", "node_type": "1", "metadata": {}, "hash": "892d766abce49f6926a9aa8768d5424e620b355ad18e55775066aed9eb364d24", "class_name": "RelatedNodeInfo"}}, "text": "Both \ngroups were comparable in terms of clinical and laboratory findings at admission. The hospital \ncourse, neurologic sequelae including deafness, and number of deaths were the same for both groups. \nThe incidence of adverse reactions also was the same except that diarrhea and thrombocytosis \noccurred significantly (P <_ 0.04) more frequently in children given moxalactam. Moxalactam was \nequivalent to ampicillin or chloramphenicol in the treatment of H. influenzae type b meningitis in \nchildren.", "start_char_idx": 412, "end_char_idx": 915, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b120fde4-fa4f-4c97-af04-9fde0fb3029e": {"__data__": {"id_": "b120fde4-fa4f-4c97-af04-9fde0fb3029e", "embedding": null, "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "d863d433-4475-4344-b4ac-5ac34a833ccd", "node_type": "4", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e38d1494703f6d2eef7ca41d10ba0a0662daa4672915973194f41d92e4ef237e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6e366ac5-3820-4023-a3b3-aee173a5b55c", "node_type": "1", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "8efce36d8cab340249e73661e157019cafd1fb7137410c93657a71addef99809", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2f6ea9d5-0962-45c2-be7e-4881854399e7", "node_type": "1", "metadata": {}, "hash": "b747209aa7d6dd40ef74eb52bb2843c2f67e697afb730b774a137d88eacd90bb", "class_name": "RelatedNodeInfo"}}, "text": "Moxalactam was \nequivalent to ampicillin or chloramphenicol in the treatment of H. influenzae type b meningitis in \nchildren. (J PEOtATR 104:447, 1984) \nSheldon L. Kaplan, M.D., Edward O. Mason, Jr., Ph.D., \nSally K. Mason, R.N., Francis I. Catlin, M.D., Rita T. Lee, M.D., \nMary Murphy, Ph.D., and Ralph D. Feigin, M.D. Houston, Texas \nllAEMOPHILus INFLUENZAE TYPE B iS the most com- \nmon organism responsible for bacterial meningitis in \nchildren younger than 5 years.", "start_char_idx": 790, "end_char_idx": 1260, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2f6ea9d5-0962-45c2-be7e-4881854399e7": {"__data__": {"id_": "2f6ea9d5-0962-45c2-be7e-4881854399e7", "embedding": null, "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "d863d433-4475-4344-b4ac-5ac34a833ccd", "node_type": "4", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e38d1494703f6d2eef7ca41d10ba0a0662daa4672915973194f41d92e4ef237e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b120fde4-fa4f-4c97-af04-9fde0fb3029e", "node_type": "1", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "94571cc97b30a594b461dcc6fd8f93bfdb87cf43fa608b67f331a72c305a1552", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d5635ba9-db72-4c20-b5f1-824b6d9e30c4", "node_type": "1", "metadata": {}, "hash": "2495b817aec8fbc15573e1c943e7badc2dc7ec459d1e13dceb65ec4c6b0fd575", "class_name": "RelatedNodeInfo"}}, "text": "Houston, Texas \nllAEMOPHILus INFLUENZAE TYPE B iS the most com- \nmon organism responsible for bacterial meningitis in \nchildren younger than 5 years. During the past 5 years in \nthe United States, approximately 20% of H I B isolates have \nbeen resistant to ampicillin, t In some areas of the country, \nstrains of HIB resistant to chloramphenicol have been \nreported? Furthermore, there have been isolates of ltlB \nresistant to ampicillin and chloramphenicol concomitant- \nly?. 4 Therefore, alternative antibiotics must be available in \nthe event that ampicillin-chloramphenicol-resistant strains \nof I{IB increase in incidence.", "start_char_idx": 1111, "end_char_idx": 1738, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d5635ba9-db72-4c20-b5f1-824b6d9e30c4": {"__data__": {"id_": "d5635ba9-db72-4c20-b5f1-824b6d9e30c4", "embedding": null, "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "d863d433-4475-4344-b4ac-5ac34a833ccd", "node_type": "4", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e38d1494703f6d2eef7ca41d10ba0a0662daa4672915973194f41d92e4ef237e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2f6ea9d5-0962-45c2-be7e-4881854399e7", "node_type": "1", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "104cefd7f5b46709d80418c1606b5094c4abd9234efc99c7302f99b4f15421bf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f2600675-2532-4c69-9b9b-9c26cf11d7b4", "node_type": "1", "metadata": {}, "hash": "f0bccf532a300384fcffbef2c6f69e24bce754f2c317de0c4e9639cba19eb9d3", "class_name": "RelatedNodeInfo"}}, "text": "4 Therefore, alternative antibiotics must be available in \nthe event that ampicillin-chloramphenicol-resistant strains \nof I{IB increase in incidence. Moxalactam is an one- \noxa-/~-lactam antibiotic that is highly active in vitro \nagainst ItlB and penetrates into cerebrospinal fluid effec- \ntively? -s Previous studies have demonstrated that moxalac- \ntam is a safe and effective antibiotic for the treatment of \nnon-central nervous system infections caused by HIB in \nFrom the Departments of Pediatrics and Otorhinolaryngology, \nBaylor College of Medicine. \nSupported in part by a grant from Eli Lilly and Company. \nReprint requests: S. L. Kaplan. M.D.. Myers-Black Infectious \nDiseases Section.", "start_char_idx": 1588, "end_char_idx": 2285, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f2600675-2532-4c69-9b9b-9c26cf11d7b4": {"__data__": {"id_": "f2600675-2532-4c69-9b9b-9c26cf11d7b4", "embedding": null, "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "d863d433-4475-4344-b4ac-5ac34a833ccd", "node_type": "4", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e38d1494703f6d2eef7ca41d10ba0a0662daa4672915973194f41d92e4ef237e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d5635ba9-db72-4c20-b5f1-824b6d9e30c4", "node_type": "1", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "3507afa0472944ca39f43eee3e228b22e68099de4881d28d025d45ebcf46d911", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8622325b-3b85-44ae-b3c3-d19486fd274b", "node_type": "1", "metadata": {}, "hash": "a4d0773882415d15c1ae880d3b5ca9e12390fa8e178cf02a360034a490ccb505", "class_name": "RelatedNodeInfo"}}, "text": "Supported in part by a grant from Eli Lilly and Company. \nReprint requests: S. L. Kaplan. M.D.. Myers-Black Infectious \nDiseases Section. Texas Children's Hospital, 6621 Fannin. Hous- \nton. TX 77030. children. 9 In March 1981, we initiated a prospective trial of \nmoxalactam compared with ampicillin or chloramphenicol \nfor the treatment of HIB meningitis in children. \nMETIIODS \nChildren admitted to Texas Children's Hospital (TCH) \nwith bacterial meningitis caused by HIB were eligible for. \nenrollment if they were 2 months of age or older. Signed, \ninformed parental consent and the consent of the private \nSee related article p. 454.", "start_char_idx": 2148, "end_char_idx": 2786, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8622325b-3b85-44ae-b3c3-d19486fd274b": {"__data__": {"id_": "8622325b-3b85-44ae-b3c3-d19486fd274b", "embedding": null, "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "d863d433-4475-4344-b4ac-5ac34a833ccd", "node_type": "4", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e38d1494703f6d2eef7ca41d10ba0a0662daa4672915973194f41d92e4ef237e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f2600675-2532-4c69-9b9b-9c26cf11d7b4", "node_type": "1", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "24509a791f987238b30c13f84f0f321c225e51cd42406b806bf33327cb8384ba", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b0695074-4415-46d5-84c3-dcb05ef29450", "node_type": "1", "metadata": {}, "hash": "c75a59c578a6eb141deb33a7bc7f8b8ad8503e2c92ec8526eb089168599223b7", "class_name": "RelatedNodeInfo"}}, "text": "enrollment if they were 2 months of age or older. Signed, \ninformed parental consent and the consent of the private \nSee related article p. 454. \nCiE Countercurrent immunoelectrophoresis \nItlB Haemophilus influenzae type b meningitis \nMBC Minimum bactericidal concentration \nPRP Polyribosephosphate \nphysician were obtained prior to the enrollment of a child \nin this study. This study was approved by the Institutional \nReview Boards of Baylor College of Medicine and TCtt. \nLumbar punctures were performed in the emergency \nroom of TCH or outlying hospitals or in offices of private \nphysicians, at which time a diagnosis of meningitis was \nestablished. When the diagnosis of bacterial meningitis \nTheJournalofPEDIATRICS 447", "start_char_idx": 2642, "end_char_idx": 3368, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b0695074-4415-46d5-84c3-dcb05ef29450": {"__data__": {"id_": "b0695074-4415-46d5-84c3-dcb05ef29450", "embedding": null, "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "aba4136e-5beb-4831-9277-1f1b51256d0b", "node_type": "4", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e45b6fc9c297694941ae987bbf1be20db0fbee1b33d7acf218a2f3f8a6363863", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8622325b-3b85-44ae-b3c3-d19486fd274b", "node_type": "1", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "db0fa6eb50cedc2f4cdada7415edfa8b0fb9fc30ba5b9a89a64f2b742f1b8b25", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4295b39f-da86-44b8-8706-535df9e144ec", "node_type": "1", "metadata": {}, "hash": "30224a93c25154eea50e6e63547e7c72cbe6967a4542dbe8c285e009b59f4e13", "class_name": "RelatedNodeInfo"}}, "text": "4 4 8 Kaplan et al. The Journal of Pediatrics \nMarch 1984 \nTable I. Characteristics of study children \nAmpicillin-chloramphenieol \nAge (too) \nDuration of illness prior to admission (days) \nDuration of fever prior to admission (days) (n = 47) Moxalactam (n = 44) \n.~ +_- I SD I Range ~ +_ , SD I Range \n13.7 \u007f 9.1 2 to 40 12.6 \u007f 10.3 4 to 54 \n2.1 \u007f 1.7 0.5 to 7 2.5 __.", "start_char_idx": 0, "end_char_idx": 368, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4295b39f-da86-44b8-8706-535df9e144ec": {"__data__": {"id_": "4295b39f-da86-44b8-8706-535df9e144ec", "embedding": null, "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "aba4136e-5beb-4831-9277-1f1b51256d0b", "node_type": "4", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e45b6fc9c297694941ae987bbf1be20db0fbee1b33d7acf218a2f3f8a6363863", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b0695074-4415-46d5-84c3-dcb05ef29450", "node_type": "1", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "863559daf7d5cb877a68fa98e372e0b8368184218f3ecc59a6901e73a9c98a6a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "86d9261a-1a83-4d8b-a789-8a20946a14e1", "node_type": "1", "metadata": {}, "hash": "253a55bdf630963888918f24ae739c0bf5a0c44febf848c3f9e9e9faf3266765", "class_name": "RelatedNodeInfo"}}, "text": "2.5 0.5 to 14 \n1.6\u007f 1.6 0to7 2.0\u007f 2.4 0.5 to 14 \nLevel of consciousness on admission n % n % \nIrritable/lethargic 38 81.0 40 91.0 \nObtunded 5 10.5 3 6.8 \nComatose 4 8.5 ! 2.3 \nSeizures prior to admission 15 32.0 ! I 25.0 \nPrior antibiotic therapy orally 19 40.0 8 18.0 \nTable 11.", "start_char_idx": 369, "end_char_idx": 648, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "86d9261a-1a83-4d8b-a789-8a20946a14e1": {"__data__": {"id_": "86d9261a-1a83-4d8b-a789-8a20946a14e1", "embedding": null, "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "aba4136e-5beb-4831-9277-1f1b51256d0b", "node_type": "4", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e45b6fc9c297694941ae987bbf1be20db0fbee1b33d7acf218a2f3f8a6363863", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4295b39f-da86-44b8-8706-535df9e144ec", "node_type": "1", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "521fa80ffda5ce03d3edb42fa61c160b2e2e6b30c0b3dad7a74198de8f46c6a6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cc9d669f-c47b-4262-ba30-9ada3e4dd36f", "node_type": "1", "metadata": {}, "hash": "2f91e00afc343f2820fa102a66da1cf601e93ed421ca4ee265edcc3a5381e9ad", "class_name": "RelatedNodeInfo"}}, "text": "2.3 \nSeizures prior to admission 15 32.0 ! I 25.0 \nPrior antibiotic therapy orally 19 40.0 8 18.0 \nTable 11. Initial CSF findings in study children \nAmpicillin-chloramphenicol \nI X +-- 1 SD Range \nTotal WBC/nmr 6890 __. 8960 \nPolymorphonuclear leukocytes (%) 87 __. 16 \nProtein (mg/dl) 211 \u007f 170 \nGlucose (mg/dl) 30 + 25 \nCSF:Blood glucose (%) 26 __.", "start_char_idx": 540, "end_char_idx": 890, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "cc9d669f-c47b-4262-ba30-9ada3e4dd36f": {"__data__": {"id_": "cc9d669f-c47b-4262-ba30-9ada3e4dd36f", "embedding": null, "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "aba4136e-5beb-4831-9277-1f1b51256d0b", "node_type": "4", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e45b6fc9c297694941ae987bbf1be20db0fbee1b33d7acf218a2f3f8a6363863", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "86d9261a-1a83-4d8b-a789-8a20946a14e1", "node_type": "1", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "24676310f313108c88b0a238184c2e2da4f43da78f671d204ae784fb826f323d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "099c6047-9593-4c6d-a8b8-8cdaf39dfb5e", "node_type": "1", "metadata": {}, "hash": "89e8045796c3ace99b94325fb74dc2cb9a3a8a758642cdf353d4aaf0f82ff88c", "class_name": "RelatedNodeInfo"}}, "text": "16 \nProtein (mg/dl) 211 \u007f 170 \nGlucose (mg/dl) 30 + 25 \nCSF:Blood glucose (%) 26 __. 20 \nPositive culture 47 \n/~-Lactamase positive 8 (17%) \nQuantitation of PRP (tlg/ml) \nMean 0.87 _ 2.0 \nMedian 0.08 \nDistribution \n0 to 0.16 30 \n0.32 to 1.28 6 \n2.56 to 10.24 6 m \nX\u007f \n30 to 38,160 5802 +_ 7804 \n28 to 100 87 __. 13 \n4 to 738 188 __. 132 \n0 to 80 38 + 32 \n0 to 77 27 __.", "start_char_idx": 806, "end_char_idx": 1175, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "099c6047-9593-4c6d-a8b8-8cdaf39dfb5e": {"__data__": {"id_": "099c6047-9593-4c6d-a8b8-8cdaf39dfb5e", "embedding": null, "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "aba4136e-5beb-4831-9277-1f1b51256d0b", "node_type": "4", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e45b6fc9c297694941ae987bbf1be20db0fbee1b33d7acf218a2f3f8a6363863", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cc9d669f-c47b-4262-ba30-9ada3e4dd36f", "node_type": "1", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "0bb510d39d1050414ebfabfc7c5b3bc8e4047b07822c48ebbd2f7c6757e60ca2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "84761669-4bc7-43e7-9437-cec149f174f4", "node_type": "1", "metadata": {}, "hash": "7c86073f8202a91ef8fd52b8ebe76c3e1f753078124deb4349a330dcb1928fac", "class_name": "RelatedNodeInfo"}}, "text": "13 \n4 to 738 188 __. 132 \n0 to 80 38 + 32 \n0 to 77 27 __. 20 \n42 \n13 (31%) \n0.54 \u007f !.75 \n0.04 \n33 \n7 \n3 Moxalactanz \nRange \n54 to 42,500 \n50 to 100 \n25 to 600 \n0 to 135 \n0 to 78 \nwas established or suspected prior to admission to TCII, \nampicillin and chloramphenicol were administered prior to \ntransfer so as not to delay therapy. As soon as possible, \nGram stain, countercurrent immunoel6ctrophoresis, or \nlatex agglutination of the CSF Was performed.", "start_char_idx": 1118, "end_char_idx": 1572, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "84761669-4bc7-43e7-9437-cec149f174f4": {"__data__": {"id_": "84761669-4bc7-43e7-9437-cec149f174f4", "embedding": null, "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "aba4136e-5beb-4831-9277-1f1b51256d0b", "node_type": "4", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e45b6fc9c297694941ae987bbf1be20db0fbee1b33d7acf218a2f3f8a6363863", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "099c6047-9593-4c6d-a8b8-8cdaf39dfb5e", "node_type": "1", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "6ec9d6e2ec0194a712101f2c419ccdb6b7ac9ee7d988fa24f9d592b161ad1a8b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f3f06a58-5cd3-4e27-a2de-3ddd2271cdb2", "node_type": "1", "metadata": {}, "hash": "6aec6aeb4cda41244b7dbb0906c0936a75c095310c1fa8dd670c680bff44725b", "class_name": "RelatedNodeInfo"}}, "text": "As soon as possible, \nGram stain, countercurrent immunoel6ctrophoresis, or \nlatex agglutination of the CSF Was performed. \nOn admission, children were randomized to either mox- \nalactam plus penicillin or ampicillin plus chloramphenicol, \nbased on a computer-generated table. Moxalactam was \nadministered at a loading dose of 100 mg/kg, followed by \n200 mg/kg/day in four divided doses intravenously. Aque- \nous penicillin G was administered at 12 million units/ \nm2/day following one third of this dose as a loading dose. \nPenicillin was discontinued as soon as a diagnosis of HIB \nmeningitis was documented by either CIE, latex agglutina- \ntion, or culture.", "start_char_idx": 1451, "end_char_idx": 2110, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f3f06a58-5cd3-4e27-a2de-3ddd2271cdb2": {"__data__": {"id_": "f3f06a58-5cd3-4e27-a2de-3ddd2271cdb2", "embedding": null, "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "aba4136e-5beb-4831-9277-1f1b51256d0b", "node_type": "4", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e45b6fc9c297694941ae987bbf1be20db0fbee1b33d7acf218a2f3f8a6363863", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "84761669-4bc7-43e7-9437-cec149f174f4", "node_type": "1", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "232ba7e0d9b36d6bad3cd39b3d81d5d11aadf5c5b536e903911edf13ee7a20e2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e47539c1-5d52-41f9-a080-87dc906ae48c", "node_type": "1", "metadata": {}, "hash": "8a0c671b2221411841a3fa0344a4b9502188a49bc53bb68723007763acbef722", "class_name": "RelatedNodeInfo"}}, "text": "Penicillin was discontinued as soon as a diagnosis of HIB \nmeningitis was documented by either CIE, latex agglutina- \ntion, or culture. Ampicillin was infused as 300 mg/kg/day \nin six divided doses after a 100 mg/kg loading dose; the \ndose of chloramphenicol was 100 mg/kg/day in four \ndivided doses intravenously. Chloramphenicol was discon- \ntinued once the HIB isolates were documented to be \nsensitive to ampicillin. Twenty-five children received one dose of ampicillin, and 23 of these 25 children also received \none dose of chloramphenicol prior to enrollment in the \nmoxalactam arm of the study.", "start_char_idx": 1975, "end_char_idx": 2577, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e47539c1-5d52-41f9-a080-87dc906ae48c": {"__data__": {"id_": "e47539c1-5d52-41f9-a080-87dc906ae48c", "embedding": null, "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "aba4136e-5beb-4831-9277-1f1b51256d0b", "node_type": "4", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e45b6fc9c297694941ae987bbf1be20db0fbee1b33d7acf218a2f3f8a6363863", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f3f06a58-5cd3-4e27-a2de-3ddd2271cdb2", "node_type": "1", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "55b36fa5684b92a8931d7e73782f52c83fbf2c914b845fc2cbf04f50b96ee212", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1c2c7974-211c-4589-9eb0-0d127d403dfd", "node_type": "1", "metadata": {}, "hash": "159e3902eb9d266c5c3974b883681e307f466ed6616bd09d3195ed5345b23ae9", "class_name": "RelatedNodeInfo"}}, "text": "Twenty-five children received one dose of ampicillin, and 23 of these 25 children also received \none dose of chloramphenicol prior to enrollment in the \nmoxalactam arm of the study. One parenteral dose of \neither antibiotic or both prior to admission did not exclude \nenrollment. \nIn the moxalactam group, a complete blood count with \ndifferential and platelet count was performed on admis- \nsion, weekly during therapy, and at the conclusion of \ntherapy. Blood urea nitrogen, serum creatinine, alkaline \nphosphatase, transaminases, and bilirubin levels (total and \ndirect) were measured at admission and at conclusion of \ntherapy.", "start_char_idx": 2396, "end_char_idx": 3027, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1c2c7974-211c-4589-9eb0-0d127d403dfd": {"__data__": {"id_": "1c2c7974-211c-4589-9eb0-0d127d403dfd", "embedding": null, "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "aba4136e-5beb-4831-9277-1f1b51256d0b", "node_type": "4", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e45b6fc9c297694941ae987bbf1be20db0fbee1b33d7acf218a2f3f8a6363863", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e47539c1-5d52-41f9-a080-87dc906ae48c", "node_type": "1", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "fef13ff84e06fbd336fab4c7eff69ac5efdc3e7b2495bb3f83f3970e8cca41f3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "110a19ca-a76e-4592-9f8c-1c67d9f59b6f", "node_type": "1", "metadata": {}, "hash": "d2fb683208e5ae6790b4c3c900d69bf10d7476c17f755e07080b1692c043a964", "class_name": "RelatedNodeInfo"}}, "text": "Blood urea nitrogen, serum creatinine, alkaline \nphosphatase, transaminases, and bilirubin levels (total and \ndirect) were measured at admission and at conclusion of \ntherapy. For the ampicillin-chloramphenicol group, a com- \nplete blood count with differential count and a platelet \ncount were obtained in 35 of 44 children at the conclusion \nof therapy. Chloramphenieol serum concentrations were \nnot monitored routinely. The patients, were observed daily, \nand careful neurologic examinations were performed at \nhospital admission and discharge. Quantitation of the \npolyribose-phosphate concentration in the initial CSF was \nperformed by twofold serial dilutions using CIE. t~", "start_char_idx": 2852, "end_char_idx": 3532, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "110a19ca-a76e-4592-9f8c-1c67d9f59b6f": {"__data__": {"id_": "110a19ca-a76e-4592-9f8c-1c67d9f59b6f", "embedding": null, "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041", "node_type": "4", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "48a1510bdcd903f8f0298c41cf2f3c0e0473c3b9f3add60301056f56afa89393", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1c2c7974-211c-4589-9eb0-0d127d403dfd", "node_type": "1", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "b8b9c89fd9530bbb8f11f307ae17482b9ed9c6cd8509a0b082291c36c432ff64", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "26fcb611-28f0-4c25-96a4-9b7c996e19f6", "node_type": "1", "metadata": {}, "hash": "ff2927940069acd60f34c993ec6f133e13268c9f684a5aa7de23c2999710b7d8", "class_name": "RelatedNodeInfo"}}, "text": "Volume 104 Moxalactam treatment of H. influenzae type b meningitis 4 4 9 \nNumber 3 \nTable III. Selected laboratory and clinical features of hospital course in study children \nAmpicillin-chloranrphenicol Moxalactam \n\"X \u007f I SD I Range I X \u007f 1 SD Range \nInitial peripheral WBC count (\u008d 10-~/mm 3) 13.6 +__ 7.2 \nInitial serum sodium (mEq/L) 134 _ 4 \nNumber <135 mEq/L 26 (55%) \nLowest serum sodium (mEq/L) 132 + 3 \nDuration of hyponatremia (hr) 18.5 \u007f 28.3 \nDuration of fever (days) 5.", "start_char_idx": 0, "end_char_idx": 481, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "26fcb611-28f0-4c25-96a4-9b7c996e19f6": {"__data__": {"id_": "26fcb611-28f0-4c25-96a4-9b7c996e19f6", "embedding": null, "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041", "node_type": "4", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "48a1510bdcd903f8f0298c41cf2f3c0e0473c3b9f3add60301056f56afa89393", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "110a19ca-a76e-4592-9f8c-1c67d9f59b6f", "node_type": "1", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "393b67619b53a859d12942c1bf33a9ec1d70d6c24029fb21f20648ba0c1d4450", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3b96abaa-2b8c-4b15-90c9-084c6f9a0349", "node_type": "1", "metadata": {}, "hash": "40bf98c35ad50fad644dd81fadd108a3a663b6b1d4e978fae07c05daa4fca976", "class_name": "RelatedNodeInfo"}}, "text": "5 \u007f 28.3 \nDuration of fever (days) 5.0 \u007f 3.6 \nAfebrile after 5 days 68% \nAfebrile after 8 days 80% \nSeizures in hospital 13 (28%) \nDuration of antibiotic therapy (days) 10.8 _ 1.7 \n>10 days 9/44 2.4 to 35.4 13.5 \u007f 8.4 3.5 to 36.2 \n118to 140 135_ 4 124to 147 \n19 (43%) \n118 to 139 133 \u007f 4 124 to 147 \n0 to 144 16.6 \u007f 38.4 0 to 240 \n0 to 16 5.", "start_char_idx": 444, "end_char_idx": 785, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3b96abaa-2b8c-4b15-90c9-084c6f9a0349": {"__data__": {"id_": "3b96abaa-2b8c-4b15-90c9-084c6f9a0349", "embedding": null, "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041", "node_type": "4", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "48a1510bdcd903f8f0298c41cf2f3c0e0473c3b9f3add60301056f56afa89393", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "26fcb611-28f0-4c25-96a4-9b7c996e19f6", "node_type": "1", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "099c27634dbe8ec1bb3999c0f751d523865b20f117d294bd00ed0fe87321b2b3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2debd2bb-cf88-4ec6-b474-b80bf2e51b68", "node_type": "1", "metadata": {}, "hash": "23781c68961b6048d86276b2a68400fbeb5886835a13ff4bf298bbee40817421", "class_name": "RelatedNodeInfo"}}, "text": "6 \u007f 38.4 0 to 240 \n0 to 16 5.3 \u007f 4.6 0 to 20 \n67% \n84% \n10 (23%) \n10 to 16 10.7 _ 1.7 10 to 17 \n6/42 \nAuditory brainstem responses were obtained at the end \nof therapy or within 1 month after discharge in all \nchildren, using a Nicolet CA-1000 Clinical Evoked \nResponse System (Nicolet Instrument Corp. Madison, \nWI). A severe to profound sensorineural hearing loss by \nauditory brainstem response was defined as no response at \nequipment limits.", "start_char_idx": null, "end_char_idx": null, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2debd2bb-cf88-4ec6-b474-b80bf2e51b68": {"__data__": {"id_": "2debd2bb-cf88-4ec6-b474-b80bf2e51b68", "embedding": null, "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041", "node_type": "4", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "48a1510bdcd903f8f0298c41cf2f3c0e0473c3b9f3add60301056f56afa89393", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3b96abaa-2b8c-4b15-90c9-084c6f9a0349", "node_type": "1", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "d5a9b14dad2406f9e51ff72c57c39f35ffc9732916914ecb777ef878eca27113", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f4e4bcfd-bff0-4631-b96a-da8d95688275", "node_type": "1", "metadata": {}, "hash": "25150ae730dae6b4663d2d5948cd8f4e3595ccd1534ae106dcff0eaa58707ec1", "class_name": "RelatedNodeInfo"}}, "text": "Madison, \nWI). A severe to profound sensorineural hearing loss by \nauditory brainstem response was defined as no response at \nequipment limits. \nAll children were admitted initially to the pediatric \nintensive care unit and received a standardized approach to \nsupportive care of a child with bacterial meningitisJ ~ \nAntibiotics were administered for a minimum of 10 days or \nlonger at the discretion of the private physician. At the \nconclusion of antibiotic therapy, a repeat lumbar puncture \nwas performed. Follow-up examinations were to be per- \nformed at 1, 3, 6, 12, and 24 months after discharge. \nDetailed psychometric evaluation was to be completed at 3 \nand 24 months after discharge.", "start_char_idx": 1060, "end_char_idx": 1755, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f4e4bcfd-bff0-4631-b96a-da8d95688275": {"__data__": {"id_": "f4e4bcfd-bff0-4631-b96a-da8d95688275", "embedding": null, "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041", "node_type": "4", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "48a1510bdcd903f8f0298c41cf2f3c0e0473c3b9f3add60301056f56afa89393", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2debd2bb-cf88-4ec6-b474-b80bf2e51b68", "node_type": "1", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "34efbfab860e1e116b70225afe470ef46c6719cdb6e819d72accdfe1397c9fdb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6b9cd269-5e33-4c9b-8931-caf3f76b1f52", "node_type": "1", "metadata": {}, "hash": "80cde501250499e20b8ec6d0e8b6a51fa48b08b7c8c8fbdd936ed004340aacb5", "class_name": "RelatedNodeInfo"}}, "text": "Detailed psychometric evaluation was to be completed at 3 \nand 24 months after discharge. \nFor purposes of this study, fever was considered present \nif the temperature exceeded 38.1~ by rectum or 37.6~ \nby mouth. Diarrhea was defined to be caused by the \nantibiotic if the child had more than three loose stools per \nday and which persisted with antibiotic therapy. Neutrope- \nnia was defined as < 1500 total neutrophils/mm 3, eosino- \nphilia as > 700 eosinophils/mm 3, and thrombocytosis as a \nplatelet count > 800,000/mm 3. Statistical analysis of the \ndata was performed using the Student t test, chi-square \nanalysis, and the Fisher exact test.", "start_char_idx": 1666, "end_char_idx": 2314, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6b9cd269-5e33-4c9b-8931-caf3f76b1f52": {"__data__": {"id_": "6b9cd269-5e33-4c9b-8931-caf3f76b1f52", "embedding": null, "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041", "node_type": "4", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "48a1510bdcd903f8f0298c41cf2f3c0e0473c3b9f3add60301056f56afa89393", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f4e4bcfd-bff0-4631-b96a-da8d95688275", "node_type": "1", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "45ec0f85d1677f5093176ee5f52cfb69f07ac88e13ef6ed8a8f31e9b99742b76", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "860d1f00-25d1-4acb-b7c1-f5f6f880562e", "node_type": "1", "metadata": {}, "hash": "5b66068df975d6a631c2798a0618eb5ad38980ea6f1b614cd6b8e685774b5e81", "class_name": "RelatedNodeInfo"}}, "text": "Statistical analysis of the \ndata was performed using the Student t test, chi-square \nanalysis, and the Fisher exact test. \nAll HIB isolates recovered from these children were \ntested for their susceptibility to moxalactam by macrotube \ndilution technique and to ampicillin and chloramphenicol \nby disk; fl-lactamase activity was determined by acidomet- \nric assay. H\" ~2 \nRESULTS \nForty-seven children were enrolled in the ampicillin- \nchloramphenicol group, and 44 children received moxalac- \ntam therapy. The age, sex, and racial distribution of the \npatients at admission, the days of illness and duration of Table IV.", "start_char_idx": 2192, "end_char_idx": 2814, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "860d1f00-25d1-4acb-b7c1-f5f6f880562e": {"__data__": {"id_": "860d1f00-25d1-4acb-b7c1-f5f6f880562e", "embedding": null, "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041", "node_type": "4", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "48a1510bdcd903f8f0298c41cf2f3c0e0473c3b9f3add60301056f56afa89393", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6b9cd269-5e33-4c9b-8931-caf3f76b1f52", "node_type": "1", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "800daf37937fe0a4c299f5cfd9fc43feb86d5ad97d97375bb113edd40027d9f7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "294390df-0ea7-40aa-936c-717e6d1ff2b9", "node_type": "1", "metadata": {}, "hash": "c9b62004bd2885eb58147ceca8621e2cadb61eba8f6b919a5e6fc7a0a88d65ad", "class_name": "RelatedNodeInfo"}}, "text": "The age, sex, and racial distribution of the \npatients at admission, the days of illness and duration of Table IV. Adverse effects of antibiotics in study children \nAmpicillin- \nchloramphenicol Moxalactam \n(n = 35) (n = 41) \nn [ % n % \nI \nNeutropenia \n<1500/mm 3 4 11.4 9 22.0 \n<1000/mm 3 2 5.7 3 7.3 \nEosinophilia >700/mm ~ 5 14.3 6 14.6 \nThrombocytosis 3 8.6 I 1 26.8 \nThrombocytopenia 1 2.9 I 2.", "start_char_idx": 2700, "end_char_idx": 3098, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "294390df-0ea7-40aa-936c-717e6d1ff2b9": {"__data__": {"id_": "294390df-0ea7-40aa-936c-717e6d1ff2b9", "embedding": null, "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041", "node_type": "4", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "48a1510bdcd903f8f0298c41cf2f3c0e0473c3b9f3add60301056f56afa89393", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "860d1f00-25d1-4acb-b7c1-f5f6f880562e", "node_type": "1", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "35161aa9fcd1acfacd7900faaac66aa7a7f0a46ddaff2d1478abaad88edc8cce", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "45530c7f-a444-43f8-b4c9-21184fd315d5", "node_type": "1", "metadata": {}, "hash": "150f0d369a59a83bb68ff4e082dd750ca548bb76505b7baa8f260473fb6edf0c", "class_name": "RelatedNodeInfo"}}, "text": "3 6 14.6 \nThrombocytosis 3 8.6 I 1 26.8 \nThrombocytopenia 1 2.9 I 2.4 \nDiarrhea 4 11.4 I I 26.8 \nMild elevation in ND 7 \ntransaminases* \nND, Not done. \n*Less than two limes normal values. \nfever prior to admission, the level of consciousness at the \ntime of admission, and the percentage of patients with \nseizures prior to admission were not significantly different \nbetween the children who received ampicillin or chloram- \nphenicol compared to those who received moxalaetam \n(Table I).", "start_char_idx": 3030, "end_char_idx": 3518, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "45530c7f-a444-43f8-b4c9-21184fd315d5": {"__data__": {"id_": "45530c7f-a444-43f8-b4c9-21184fd315d5", "embedding": null, "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041", "node_type": "4", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "48a1510bdcd903f8f0298c41cf2f3c0e0473c3b9f3add60301056f56afa89393", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "294390df-0ea7-40aa-936c-717e6d1ff2b9", "node_type": "1", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "befeec8d79f694a9a3168beb5eebcd55ba8b045d0f686114ac34b139fd64731a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1404f48b-f50c-4e2c-87b3-bd7e8ec8f3ab", "node_type": "1", "metadata": {}, "hash": "c388acdff38bd630bed5d9c23f5252ac561f6daab6c86e8f490a5c33b63d038d", "class_name": "RelatedNodeInfo"}}, "text": "Forty percent of the children in the ampicillin- \nchloramphenicol group received prior antibiotic therapy \norally, compared with 18% in the moxalactam group \n(X 2 = 5.39, P = 0.02). One child in each group had buccal \ncellulitis in association with the meningitis. \nThe CSF findings at admission were not significantly \ndifferent between the two groups (Table I1). Two of the \nchildren in the moxalactam group had sterile CSF cultures \nand a CIE test negative for HIB, but the latex agglutina- \ntion was positive for HIB in the CSF.", "start_char_idx": 3519, "end_char_idx": 4051, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1404f48b-f50c-4e2c-87b3-bd7e8ec8f3ab": {"__data__": {"id_": "1404f48b-f50c-4e2c-87b3-bd7e8ec8f3ab", "embedding": null, "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5d5d60e5-7647-43b4-a9b9-c8b07b310041", "node_type": "4", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "48a1510bdcd903f8f0298c41cf2f3c0e0473c3b9f3add60301056f56afa89393", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "45530c7f-a444-43f8-b4c9-21184fd315d5", "node_type": "1", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "6fba20aa7d7d304b0162d0d87e4891783d8c1a3ee4301f6719bf4b2d6b84b531", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ed749120-b03f-46b2-b747-55f47aaac973", "node_type": "1", "metadata": {}, "hash": "d4905d5aaba78037558a5dfa19e0ed6fbe737876cad8d238edbb340bd8c587e7", "class_name": "RelatedNodeInfo"}}, "text": "Two of the \nchildren in the moxalactam group had sterile CSF cultures \nand a CIE test negative for HIB, but the latex agglutina- \ntion was positive for HIB in the CSF. All HIB isolates \nfrom both groups were sensitive to moxalactam: \nMBCso=0.016 tag/ml, MBCgo=0.06 #g/ml; MBC \nrange < 0.001 to 0.5/~g/ml. \nThe hospital course in both groups was similar (Table \nII1). The mean serum sodium concentration at the time of", "start_char_idx": 3884, "end_char_idx": 4301, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ed749120-b03f-46b2-b747-55f47aaac973": {"__data__": {"id_": "ed749120-b03f-46b2-b747-55f47aaac973", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "b6ba3113f39dd46081bef25a64d546cd04abd036c0319ff812982f7bd7f6957c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1404f48b-f50c-4e2c-87b3-bd7e8ec8f3ab", "node_type": "1", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "52078e02062341e3ae21890d8767f206cb9dff8a069963ce2958fbaa282cf35f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8e86ca9e-3616-4894-85cc-25e31416452a", "node_type": "1", "metadata": {}, "hash": "952bfde58f3364cc420d8b541bf3e1f9015d92c87edd3e0eaf3a3afcdf57287c", "class_name": "RelatedNodeInfo"}}, "text": "450 Kaplan et al. The Journal of Pediatrics \nMarch 1984 \nadmission, the lowest serum sodium concentration in the \nhospital, and the duration of hyponatremia and fever were \nequivalent for both groups. One child developed a warm, \nswollen elbow on day 5 of moxalactam therapy. The joint \nfluid was positive for HIB by CIE, but culture negative. \nThe patient was given 14 days of moxalactam, with \ncomplete resolution of the arthritis.", "start_char_idx": 0, "end_char_idx": 433, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8e86ca9e-3616-4894-85cc-25e31416452a": {"__data__": {"id_": "8e86ca9e-3616-4894-85cc-25e31416452a", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "b6ba3113f39dd46081bef25a64d546cd04abd036c0319ff812982f7bd7f6957c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ed749120-b03f-46b2-b747-55f47aaac973", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "579409972f058a287d01bf53eae91aae57566a9444a3d92374c7712cb091f04e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "15859d1f-cf7e-42f7-a393-c4df7088ff4c", "node_type": "1", "metadata": {}, "hash": "06926d175e6376e6e71b0e580ea3748418994f4f7828e1add928ad67b9db915a", "class_name": "RelatedNodeInfo"}}, "text": "The joint \nfluid was positive for HIB by CIE, but culture negative. \nThe patient was given 14 days of moxalactam, with \ncomplete resolution of the arthritis. The CSF findings \nobtained within 24 hours of discontinuing antibiotic thera- \npy were the same except that the total WBC count in the\" \nampicillin-chloramphenicol group was significantly great- \ner (t = 2.79, P<0.01) than that in the moxalactam \ngroup. \nAdverse effects. Neutropenia was noted in four of 35 \nchildren in the ampicillin-chloramphenicol group (Table \nIV). All four children had received ampicillin.", "start_char_idx": 276, "end_char_idx": 847, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "15859d1f-cf7e-42f7-a393-c4df7088ff4c": {"__data__": {"id_": "15859d1f-cf7e-42f7-a393-c4df7088ff4c", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "b6ba3113f39dd46081bef25a64d546cd04abd036c0319ff812982f7bd7f6957c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8e86ca9e-3616-4894-85cc-25e31416452a", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "a40b3bdd22d423907f324e8c4e5f0554f9b57e0e7d2b9dc5fa7a83ce5f0c7564", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a14a78f8-9f82-42dd-88ee-65b6feca9b87", "node_type": "1", "metadata": {}, "hash": "54de47891dff1be463f51e678f33bdaca6e9e7323d3ca68f6a217320f4aa8db2", "class_name": "RelatedNodeInfo"}}, "text": "Adverse effects. Neutropenia was noted in four of 35 \nchildren in the ampicillin-chloramphenicol group (Table \nIV). All four children had received ampicillin. In the \nmoxalactam group, the incidence of neutropenia was not \nsignificantly different than in the control group. In five \ninstances, the neutrophil count increased during moxalac- \ntam therapy. No complications of the neutropenia were \nnoted in either group. Eosinophilia was noted in five \npatients in the ampicillin-ehloramphenicol group (four of \nfive associated with ampicillin) and in six patients in the \nmoxalactam group.", "start_char_idx": 689, "end_char_idx": 1278, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a14a78f8-9f82-42dd-88ee-65b6feca9b87": {"__data__": {"id_": "a14a78f8-9f82-42dd-88ee-65b6feca9b87", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "b6ba3113f39dd46081bef25a64d546cd04abd036c0319ff812982f7bd7f6957c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "15859d1f-cf7e-42f7-a393-c4df7088ff4c", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "0a7f08027c467ca0abc1784e3db6701a7379c094f3cd9291012e9be79c6affec", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "64bd04da-df4c-4973-94cd-c7fcaeedb714", "node_type": "1", "metadata": {}, "hash": "d31b74aa85304b0a08e261e45f5413fd9799a77c07a1a28bc052f112e56227c6", "class_name": "RelatedNodeInfo"}}, "text": "Eosinophilia was noted in five \npatients in the ampicillin-ehloramphenicol group (four of \nfive associated with ampicillin) and in six patients in the \nmoxalactam group. The incidence of thrombocytosis was \nsignificantly greater (X: = 4.19, P = 0.04) in the moxalac- \ntam group than in the ampicillin-chloramphenicol group. \nDiarrhea was noted in 11 of the 42 surviving patients who \nreceived moxalactam, compared with four of the 44 \nsurviving patients given ampicillin-ehloramphenicol \n(x 2= 4.36, P = 0.037). In many instances the diarrhea \nimproved during moxalactam therapy.", "start_char_idx": 1109, "end_char_idx": 1688, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "64bd04da-df4c-4973-94cd-c7fcaeedb714": {"__data__": {"id_": "64bd04da-df4c-4973-94cd-c7fcaeedb714", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "b6ba3113f39dd46081bef25a64d546cd04abd036c0319ff812982f7bd7f6957c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a14a78f8-9f82-42dd-88ee-65b6feca9b87", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "d004e279386235c33ac1a2d4d184f49a37eb77d8c71b98d92ac9f66d504fcb2a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "69f8d83e-18b3-4607-8420-f11c9e6f697b", "node_type": "1", "metadata": {}, "hash": "ecb6f8dac773a5054bbf014a9987ba0b7a0394444049ac1be59608d5664c67ba", "class_name": "RelatedNodeInfo"}}, "text": "In many instances the diarrhea \nimproved during moxalactam therapy. Six patients in the \nmoxalactam group had a Candida diaper rash. There were \nno episodes of bleeding in either group. \nOutcome. One half of the patients in each group have \nbeen seen in follow-up for at least 1 year after discharge. \nForty of the children in the ampicillin-chloramphenicol \ngroup have had no physical sequelae in follow-up from \nbetween 1 month and 2 years after discharge. One of these \nchildren is hyperactive. Three children have severe to \nprofound bilateral sensorineural deafness, and two of these \nchildren have ataxia, which has improved. Two children \nhave profound neurologic sequelae from their disease.", "start_char_idx": 1621, "end_char_idx": 2320, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "69f8d83e-18b3-4607-8420-f11c9e6f697b": {"__data__": {"id_": "69f8d83e-18b3-4607-8420-f11c9e6f697b", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "b6ba3113f39dd46081bef25a64d546cd04abd036c0319ff812982f7bd7f6957c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "64bd04da-df4c-4973-94cd-c7fcaeedb714", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "cb4ab3faf405fb0d2b0616af8b7deafe11067a342b1f8f9646832f31b85ab205", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "520dfa32-0f3a-4110-a50c-f282d9cc1c23", "node_type": "1", "metadata": {}, "hash": "4ff2ac3ecc4fbadd46a6da59d8d0c9bb4873e994a67ff0d8d88745c4b15dee65", "class_name": "RelatedNodeInfo"}}, "text": "Three children have severe to \nprofound bilateral sensorineural deafness, and two of these \nchildren have ataxia, which has improved. Two children \nhave profound neurologic sequelae from their disease. One \nchild was lSA, years of age when he was hospitalized with a \n6-day history of fever and lethargy. We was semicomatose \nwith a right hemiparesis at the time of admission, and the \ninitial quantitative CIE was 10.24 t~g/ml. The child at \nfollow-up has bilateral profound sensorineural hearing \nloss, severe developmental delay, a right hemiparesis, and \ncortical blindness.", "start_char_idx": 2119, "end_char_idx": 2697, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "520dfa32-0f3a-4110-a50c-f282d9cc1c23": {"__data__": {"id_": "520dfa32-0f3a-4110-a50c-f282d9cc1c23", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "b6ba3113f39dd46081bef25a64d546cd04abd036c0319ff812982f7bd7f6957c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "69f8d83e-18b3-4607-8420-f11c9e6f697b", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "09583e29f4c90c53f1334cb8322024d5908e4054d4019c71e1002cd15f393bc4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "59eb8509-419c-48ea-ac83-2cc819e8df25", "node_type": "1", "metadata": {}, "hash": "c6fb19a27881ac0a3d7a57f5cf271d68ffe0cc2900e91aea1b919ca3b6a9a310", "class_name": "RelatedNodeInfo"}}, "text": "The child at \nfollow-up has bilateral profound sensorineural hearing \nloss, severe developmental delay, a right hemiparesis, and \ncortical blindness. A second child was 2~/1, months of age \nand had a 24-hour history of illness with seizures and a \nrespiratory arrest prior to admission. She has profound \ndevelopmental delay and microcephaly and requires exog- \nenous vasopressin. One child with normal neurologic examination results had a single, generalized seizure 9 \nmonths after discharge. His EEG findings are normal, and \nhe continues to take phenobarbital without additional \nseizures. \nThree children in the ampicillin-chloramphenieol group \ndied.", "start_char_idx": 2548, "end_char_idx": 3204, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "59eb8509-419c-48ea-ac83-2cc819e8df25": {"__data__": {"id_": "59eb8509-419c-48ea-ac83-2cc819e8df25", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "b6ba3113f39dd46081bef25a64d546cd04abd036c0319ff812982f7bd7f6957c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "520dfa32-0f3a-4110-a50c-f282d9cc1c23", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "4ca2e19c735c64d900f26a29feb1a4a89773151a600739a57709a5d941bb5e6d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "23bb07db-3dc6-44fe-ba08-7f280da80532", "node_type": "1", "metadata": {}, "hash": "5ccbd2acdefaf0657ffd4491e6af52e58fdd700137ec4dd41387f0f3745cb6fd", "class_name": "RelatedNodeInfo"}}, "text": "His EEG findings are normal, and \nhe continues to take phenobarbital without additional \nseizures. \nThree children in the ampicillin-chloramphenieol group \ndied. One death occurred in a 1~',2-year-old child with a \n12-hour history of illness prior to admission. She was \nunresponsive, in shock, and immediately required ventila- \ntory support at the time of admission; on the third hospital \nday, an EEG showed no cortical activity. A second child \nwas 2 years of age with a l-day history of fever and \nvomiting, and on admission was comatose, in shock, and \nhad fixed dilated pupils; the child expired on the second \nhospital day.", "start_char_idx": 3043, "end_char_idx": 3674, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "23bb07db-3dc6-44fe-ba08-7f280da80532": {"__data__": {"id_": "23bb07db-3dc6-44fe-ba08-7f280da80532", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "b6ba3113f39dd46081bef25a64d546cd04abd036c0319ff812982f7bd7f6957c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "59eb8509-419c-48ea-ac83-2cc819e8df25", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "9d5db7fdbf2c231fb80447ebb8116ef8094616b755ad96721ea7413699c36da6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a35ab5ca-cb22-4893-87e6-9ceaf1a21ef0", "node_type": "1", "metadata": {}, "hash": "f259d947f504e427503bb97e632fc47a897023d89684e58b6d52d1cb420b83b0", "class_name": "RelatedNodeInfo"}}, "text": "The third death occurred in a 1\u000190 \nchild with a 12-hour illness and seizures prior to admission. \nThe patient had anisocoria and was semi-comatose on \nadmission; an EEG was isoelectric within 24 hours of \nadmission. \nIn the moxalactam group, 37 children were considered \nnormal at follow-up, although two did exhibit hyperactivi- \nty. Two children had profound, bilateral sensorineural \nhearing losses with ataxia, which has improved. One of \nthese children developed seizures 9 months after discharge. \nThree children had other significant neurologic sequelae. \nA 4-month-old infant was ill < 12 hours prior to admission, \nrequired ventilatory support, and had prolonged focal \nseizures during the hospitalization.", "start_char_idx": 3675, "end_char_idx": 4391, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a35ab5ca-cb22-4893-87e6-9ceaf1a21ef0": {"__data__": {"id_": "a35ab5ca-cb22-4893-87e6-9ceaf1a21ef0", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "b6ba3113f39dd46081bef25a64d546cd04abd036c0319ff812982f7bd7f6957c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "23bb07db-3dc6-44fe-ba08-7f280da80532", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "048f6e1c328ce2b3178da999cd1f41557b30fbcffb8fd5c02d04224844689603", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "46fdc0f7-bbda-4ee5-bdb9-f0dd2e4fef86", "node_type": "1", "metadata": {}, "hash": "2b47de43c84a02ab737dfeac2e6f73b89e29513ca406ff8f74f1ba4713f14e3b", "class_name": "RelatedNodeInfo"}}, "text": "Three children had other significant neurologic sequelae. \nA 4-month-old infant was ill < 12 hours prior to admission, \nrequired ventilatory support, and had prolonged focal \nseizures during the hospitalization. At follow-up he has \ndevelopmental delay and generalized hypotonia. A second \n4-month-old child had fever for 6 days prior to admission \nand also had prolonged focal seizures during the hospital- \nization. At follow-up she has quadriparesis and global \nretardation. A 6-month-old child had a 4-day history of \nfever and on admission was noted to have a right hemipare- \nsis. In the hospital, the patient had generalized persistent \nseizures, and at follow-up has generalized hypotonia and \ndevelopmental delay.", "start_char_idx": 4180, "end_char_idx": 4902, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "46fdc0f7-bbda-4ee5-bdb9-f0dd2e4fef86": {"__data__": {"id_": "46fdc0f7-bbda-4ee5-bdb9-f0dd2e4fef86", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "b6ba3113f39dd46081bef25a64d546cd04abd036c0319ff812982f7bd7f6957c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a35ab5ca-cb22-4893-87e6-9ceaf1a21ef0", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "cf350e74e89b4b863345369c43738fd06c53910e75fff4f7f38526a8820e7cbd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cc893d8c-ea56-4c2e-bfd7-44163d19a56f", "node_type": "1", "metadata": {}, "hash": "8d55fcdecdb972d49fa84bbb9081ff02c2c8b8eb5525c1eda565b03f436e5449", "class_name": "RelatedNodeInfo"}}, "text": "In the hospital, the patient had generalized persistent \nseizures, and at follow-up has generalized hypotonia and \ndevelopmental delay. \nTwo patients in the moxalactam group died. A 5- \nmonth-old infant had a 4-day history of irregular breath- \ning, and was obtunded and in shock on admission. Initial \nCSF quantitation of PRP by CIE was 10.24 pg/ml. The \nhospital course was complicated by prolonged seizures, \npneumonia and empyema, pyogenic arthritis, and diabetes \ninsipidus. A ventricular tap done prior to death revealed \nsterile ventricular fluid. A second child was 23A years of \nage, and on admission was comatose with fixed, dilated \npupils and no spontaneous respirations.", "start_char_idx": 4767, "end_char_idx": 5450, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "cc893d8c-ea56-4c2e-bfd7-44163d19a56f": {"__data__": {"id_": "cc893d8c-ea56-4c2e-bfd7-44163d19a56f", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "b6ba3113f39dd46081bef25a64d546cd04abd036c0319ff812982f7bd7f6957c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "46fdc0f7-bbda-4ee5-bdb9-f0dd2e4fef86", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "469c65a8f0d60f289aa5b1592c9845d81dd20038056eb7040ab305f1048182a3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d84b3478-90f6-473a-ba87-d79c2c6d1f28", "node_type": "1", "metadata": {}, "hash": "dde89117d85eed712f921238af710caecebfb514a58b174295e6b2cb3b51b045", "class_name": "RelatedNodeInfo"}}, "text": "A second child was 23A years of \nage, and on admission was comatose with fixed, dilated \npupils and no spontaneous respirations. An EEG showed \nbrain death 12 hours after admission to the hospital. \nFive of 86 (5.8%) surviving children had severe to \nprofound bilateral hearing loss as a result of the HIB \nmeningitis (Table V). There was no association between \nduration of illness prior to admission and the occurrence of \nsevere hearing loss in this group of patients. Two of 59", "start_char_idx": 5322, "end_char_idx": 5803, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d84b3478-90f6-473a-ba87-d79c2c6d1f28": {"__data__": {"id_": "d84b3478-90f6-473a-ba87-d79c2c6d1f28", "embedding": null, "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0", "node_type": "4", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "c3cc8745a2baf79897ea02c220ddf5e99955b65e7fc4bafb1e0ed82a2c9a6497", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cc893d8c-ea56-4c2e-bfd7-44163d19a56f", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "ff05cf7009a683deeebecf647700fe1c430f7c5269c8998df6cd72981214bdb1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "da72eb85-5958-4c85-bb21-003423e68378", "node_type": "1", "metadata": {}, "hash": "26efe3b130bd1b91793e85d61ae7600f16279812933aae9c82261b06333e2d65", "class_name": "RelatedNodeInfo"}}, "text": "Volume 104 Moxalactam treatment of H. influenzae type b meningitis 4 5 1 \nNumber 3 \nTable V. Selected characteristics of children with profound sensorineural hearing loss \nQuantitative \nCSF cell CSF glucose PRP determination \nSeizures count ~/mm J) ~mg/dl) in CSF (gm/ml) Age at Duration of \nonset illness prior \nO'r) to admission \n\"A2 36 hr - 3,039 4 5.12 \nVt2 48 hr + Clumped 2 5.12 \n2SA~ 3 day - 3:800 15 0.64 \n~\u000188 5 days + 42,500 <10 5.12 \n1~2 6 days + 38,160 5 10.", "start_char_idx": 0, "end_char_idx": 470, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "da72eb85-5958-4c85-bb21-003423e68378": {"__data__": {"id_": "da72eb85-5958-4c85-bb21-003423e68378", "embedding": null, "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0", "node_type": "4", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "c3cc8745a2baf79897ea02c220ddf5e99955b65e7fc4bafb1e0ed82a2c9a6497", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d84b3478-90f6-473a-ba87-d79c2c6d1f28", "node_type": "1", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "ed86fedc18280f7bf20a35f75d9839ed84f21bca78b3d1965a3ad2af881d6216", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8a78a7de-fc0e-46e5-bc3c-26a619c700a1", "node_type": "1", "metadata": {}, "hash": "45bca790dc756fafe6e1b11011b0d2222c03c08c2db22c0d494ce78a6c4992e8", "class_name": "RelatedNodeInfo"}}, "text": "64 \n~\u000188 5 days + 42,500 <10 5.12 \n1~2 6 days + 38,160 5 10.24 Prolonged \nfever \n(days) Therapy \n9 Chloramphenicol \n- Ampicillin \n- Moxalactam \n- Moxalactam \n11 Chloramphenicol \n(3.4%) children who were ill 2 or fewer days, compared \nwith three of 27 (I 1.1%) who were ill 3 days or more prior \nto admission, had significant hearing losses (Fisher exact \ntest, P = 0.19). However, both the initial CSF glucose \nconcentration and quantitative PRP concentration by CIE \nwere associated with hearing losses.", "start_char_idx": 410, "end_char_idx": 914, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8a78a7de-fc0e-46e5-bc3c-26a619c700a1": {"__data__": {"id_": "8a78a7de-fc0e-46e5-bc3c-26a619c700a1", "embedding": null, "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0", "node_type": "4", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "c3cc8745a2baf79897ea02c220ddf5e99955b65e7fc4bafb1e0ed82a2c9a6497", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "da72eb85-5958-4c85-bb21-003423e68378", "node_type": "1", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "6859950de7ce4f1b9aeac885534c51dd42144692b96c20902b6d0404f8a84ca4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a32bb617-616d-4900-bc75-90ce1ff77546", "node_type": "1", "metadata": {}, "hash": "d74cc6e3eb9171d2ca8e14230e761c0aea5e8f8d337a92ebb6e2b23737c44734", "class_name": "RelatedNodeInfo"}}, "text": "had significant hearing losses (Fisher exact \ntest, P = 0.19). However, both the initial CSF glucose \nconcentration and quantitative PRP concentration by CIE \nwere associated with hearing losses. One of 63 (1.6%) \nchildren with a CSF glucose concentration > 10 mg/dl, \ncompared with four of 22 (18%) with an initial CSF \nglucose concentration < 10 mg/dl, had severe hearing \ndeficits (Fisher exact test, P = 0.016). One of 72 children \nwith CSF PRP concentrations up to 1.28 tag/ml and four \nof 8 with values between 2.56 and 10.24 t~g/ml had severe \nhearing loss (Fisher exact test, P = 0.002).", "start_char_idx": 719, "end_char_idx": 1314, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a32bb617-616d-4900-bc75-90ce1ff77546": {"__data__": {"id_": "a32bb617-616d-4900-bc75-90ce1ff77546", "embedding": null, "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0", "node_type": "4", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "c3cc8745a2baf79897ea02c220ddf5e99955b65e7fc4bafb1e0ed82a2c9a6497", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8a78a7de-fc0e-46e5-bc3c-26a619c700a1", "node_type": "1", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "ee1adda328b2d6413428c0b38d77567a32c861c8acb7fd17b17fe26f7512af36", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "46381ef6-bf54-4f70-b983-21cd466c021f", "node_type": "1", "metadata": {}, "hash": "bec52fadaed0f3edbacf600153188e3f557edf25c557343319a08af3c20a571c", "class_name": "RelatedNodeInfo"}}, "text": "DISCUSSION \nPrevious investigations have demonstrated that moxa- \nlactam is an effective agent in the treatment of a wide \nvariety of infections, including meningitis caused by gram- \nnegative enteric organisms, in both adults and chil- \ndren:'\"\" In one study, six of seven children with HIB \nmeningitis (none ampicillin resistant) who were given \nmoxalactam had a satisfactory clinical response.16 In a \nsecond report of 27 children with HIB meningitis treated \nwith moxalactam, 26 survived and neurologie sequelae \nwere noted in four. 19 None of these initial reports compared \nmoxalactam with established antibiotics for the treatment \nof HIB meningitis.", "start_char_idx": 1316, "end_char_idx": 1973, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "46381ef6-bf54-4f70-b983-21cd466c021f": {"__data__": {"id_": "46381ef6-bf54-4f70-b983-21cd466c021f", "embedding": null, "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0", "node_type": "4", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "c3cc8745a2baf79897ea02c220ddf5e99955b65e7fc4bafb1e0ed82a2c9a6497", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a32bb617-616d-4900-bc75-90ce1ff77546", "node_type": "1", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "26f265e618a9edb3f8a03f58536c5a45708dee5b5f0b786caf3fa8b7806c8363", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ac84563f-2d04-4318-8d04-08658385cefc", "node_type": "1", "metadata": {}, "hash": "b6ce05a7de11630158bee2d5b85e34e65447f9b0661df9f30e1c670990b53b05", "class_name": "RelatedNodeInfo"}}, "text": "19 None of these initial reports compared \nmoxalactam with established antibiotics for the treatment \nof HIB meningitis. Moxalactam does not appear useful for \nthe treatment of meningitis caused by gram-positive agents \nsuch as Streptococcus pneumoniae or group B streptococ- \ncus. Is \nMoxalactam was shown to be equivalent to ampicillin or \nchloramphenicol for the treatment of IIIB meningitis in \nchildren. Many of the clinical and laboratory variables \nthat correlate with outcome of bacterial meningitis were \nthe same in both groups. The only significant difference \nwas that more children in the ampicillin-chloramphenieol \ngroup than in the moxalactam group received antibiotics \norally prior to admission.", "start_char_idx": 1853, "end_char_idx": 2566, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ac84563f-2d04-4318-8d04-08658385cefc": {"__data__": {"id_": "ac84563f-2d04-4318-8d04-08658385cefc", "embedding": null, "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0", "node_type": "4", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "c3cc8745a2baf79897ea02c220ddf5e99955b65e7fc4bafb1e0ed82a2c9a6497", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "46381ef6-bf54-4f70-b983-21cd466c021f", "node_type": "1", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "551a70bf497372282b8e7edd5bcf02ec87c6d8dfffd9431da0e9d9d8fc6201b3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2e4a3692-d6d6-4d4e-80ea-7761ab80756e", "node_type": "1", "metadata": {}, "hash": "aa85cef09725fafc3ba94ddb993fb7643113ddb54b585fe5b1f7dc05350f62c7", "class_name": "RelatedNodeInfo"}}, "text": "The only significant difference \nwas that more children in the ampicillin-chloramphenieol \ngroup than in the moxalactam group received antibiotics \norally prior to admission. The clinical courses in the \nhospital were virtually identical. Both groups of children \nhave been observed carefully, and more than half of the \nchildren in each group have been seen for up to a year after discharge from the hospital. Forty of 44 (91%) survivors in \nthe ampicillin-chloramphenicol group and 37 of 42 (88%) \nsurvivors in the moxalactam group were considered to have \nno neurologic abnormalities as a result of meningitis at \ntheir last follow-up visit.", "start_char_idx": 2392, "end_char_idx": 3036, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2e4a3692-d6d6-4d4e-80ea-7761ab80756e": {"__data__": {"id_": "2e4a3692-d6d6-4d4e-80ea-7761ab80756e", "embedding": null, "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0", "node_type": "4", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "c3cc8745a2baf79897ea02c220ddf5e99955b65e7fc4bafb1e0ed82a2c9a6497", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ac84563f-2d04-4318-8d04-08658385cefc", "node_type": "1", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "2cc38174f4c100f49b15cbdd3e41f387a5c8a2d75f1515035c67e9adb1215782", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "46bb668f-3a1f-4e5d-b6ad-6be40de3b4f1", "node_type": "1", "metadata": {}, "hash": "fe4f09bf0fc7afab3ccb8f1db242e30c8d254407ab5ba358da71b649b6d7dc10", "class_name": "RelatedNodeInfo"}}, "text": "In particular, moxalactam was \neffective in the treatment of ampicillin-resistant ItlB \nmeningitis in 13 children. We do not believe that the \noutcome of the five children who died and of the five who \nhave significant neurologic damage in the combined group \ncould have been altered by antimicrobial therapy. \nFive children (5.8%) in the total group of survivors have \nsevere to profound, bilateral sensorineural hearing loss. \nThis incidence of severe hearing loss is equivalent to that \nnoted previously after HIB meningitis. 2~ Furthermore, this \nstudy confirms the association between low CSF glucose \non admission and subsequent severe hearing loss related to \nmeningitis.", "start_char_idx": 3037, "end_char_idx": 3715, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "46bb668f-3a1f-4e5d-b6ad-6be40de3b4f1": {"__data__": {"id_": "46bb668f-3a1f-4e5d-b6ad-6be40de3b4f1", "embedding": null, "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0", "node_type": "4", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "c3cc8745a2baf79897ea02c220ddf5e99955b65e7fc4bafb1e0ed82a2c9a6497", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2e4a3692-d6d6-4d4e-80ea-7761ab80756e", "node_type": "1", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "eaeb018d9aa00204053f149e06abec253685625ae41360264cca4fde4ff1797e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "048546fa-55b9-43b2-ba78-cb525e86a123", "node_type": "1", "metadata": {}, "hash": "4ac0f20aec51660e75588e6d61ab936fecb288dd76388245788227c0a5d0ca82", "class_name": "RelatedNodeInfo"}}, "text": "2~ Furthermore, this \nstudy confirms the association between low CSF glucose \non admission and subsequent severe hearing loss related to \nmeningitis. \nIn a previous report, we noted that neutropenia occurred \nin a high percentage (43%) of children who received \nmoxalactam for non-central nervous system infections: In \nthis study, neutropenia developed in nine of 41 (22%) \nchildren who received moxalactam, but this was not \ndifferent than the incidence of neutropenia in the ampicil- \nlin-chloramphenicol group. None of the children experi- \nenced any adverse effects referable to the neutropenia. \nThrombocytosis and diarrhea occurred more commonly in \nthe children given moxalactam.", "start_char_idx": 3566, "end_char_idx": 4253, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "048546fa-55b9-43b2-ba78-cb525e86a123": {"__data__": {"id_": "048546fa-55b9-43b2-ba78-cb525e86a123", "embedding": null, "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0", "node_type": "4", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "c3cc8745a2baf79897ea02c220ddf5e99955b65e7fc4bafb1e0ed82a2c9a6497", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "46bb668f-3a1f-4e5d-b6ad-6be40de3b4f1", "node_type": "1", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "fcd604c104f6973a9bbc1dfc0b86cf55c1157d4217970009d91e27d71165636c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e434d935-f7b1-477e-aaa4-c3e3ec17e050", "node_type": "1", "metadata": {}, "hash": "966f44363c008093ba4e955a59b4b53e3c853772c3fff8accc1a47dd9b6fe2eb", "class_name": "RelatedNodeInfo"}}, "text": "None of the children experi- \nenced any adverse effects referable to the neutropenia. \nThrombocytosis and diarrhea occurred more commonly in \nthe children given moxalactam. The cause of moxalactam- \ninduced neutropenia or thrombocytosis is not known. \nWe did not encounter any episode of bleeding in these \nchildren, and vitamin K was not administered to any \npatient. However, inasmuch as prothrombin or bleeding \ntimes were not performed, we could not determine specifi- \ncally the effect of moxalactam on hemostasis in children. \nVitamin K-dependent hypoprothrombinemia, abnormali- \nties in platelet aggregation, and significant hemorrhage \nhave been described in patients receiving moxalactam.", "start_char_idx": 4081, "end_char_idx": 4778, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e434d935-f7b1-477e-aaa4-c3e3ec17e050": {"__data__": {"id_": "e434d935-f7b1-477e-aaa4-c3e3ec17e050", "embedding": null, "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ea199b63-3470-44b2-ac1a-0efb10f163e0", "node_type": "4", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "c3cc8745a2baf79897ea02c220ddf5e99955b65e7fc4bafb1e0ed82a2c9a6497", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "048546fa-55b9-43b2-ba78-cb525e86a123", "node_type": "1", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "cc93e686f5139eb5d665763a09f5ae9667591e130e5a15b836b580d9bca2d629", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6320e6a3-0d3b-46f8-b318-3d2e11911304", "node_type": "1", "metadata": {}, "hash": "da1650ae804781edf271ae9d6afe2279e8cf1a8c57929836f5a75756e9d9cb19", "class_name": "RelatedNodeInfo"}}, "text": "Vitamin K-dependent hypoprothrombinemia, abnormali- \nties in platelet aggregation, and significant hemorrhage \nhave been described in patients receiving moxalactam. \"'22 \nCurrently, prophylactic administration of vitamin K is \nrecommended once a week, and bleeding times should be \ndetermined in patients who receive high doses of moxalac- \ntam for longer than 3 days. Further experience in chroni- \ncally ill children with serious infection is required before", "start_char_idx": 4614, "end_char_idx": 5074, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6320e6a3-0d3b-46f8-b318-3d2e11911304": {"__data__": {"id_": "6320e6a3-0d3b-46f8-b318-3d2e11911304", "embedding": null, "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3912338c-7bfe-4182-b003-f8473c2f2a85", "node_type": "4", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "842d81a39966dc9bac383c7e6a2226ef7bdc3001279b796df62f1e2072e91e73", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e434d935-f7b1-477e-aaa4-c3e3ec17e050", "node_type": "1", "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "f089a2c787c7d7d1b5d5f70dc0f58df0e9f1f1a7f8028d18d6b198f2b51120d6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "404bd5dd-4f3a-41f8-9d7a-ca0352f47cff", "node_type": "1", "metadata": {}, "hash": "5e147b90c593251b5ea7ff8274faf95507ffc5051f1716e345a5b83de4989c44", "class_name": "RelatedNodeInfo"}}, "text": "4 5 2 Kaplan et al. The Journal of Pediatrics \nMarch 1984 \nthe importance of alterations of hemostasis induced by \nmoxalactam can be determined. \nMoxalactam at a dose of 200 mg/kg/day in four divided \ndoses intravenously proved to be equivalent to ampicillin or \nchloramphenieol in the treatment of HIB meningitis in \nchildren. Moxalactam should not be used alone as the \ninitial therapy of meningitis in children because of its \nrelatively poor activity against S. pneumoniae.", "start_char_idx": 0, "end_char_idx": 477, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "404bd5dd-4f3a-41f8-9d7a-ca0352f47cff": {"__data__": {"id_": "404bd5dd-4f3a-41f8-9d7a-ca0352f47cff", "embedding": null, "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3912338c-7bfe-4182-b003-f8473c2f2a85", "node_type": "4", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "842d81a39966dc9bac383c7e6a2226ef7bdc3001279b796df62f1e2072e91e73", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6320e6a3-0d3b-46f8-b318-3d2e11911304", "node_type": "1", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "4466fe7bfe5d338d3e769e1e6bdf43afbd3f76fa41b52f1cc056997214c3f645", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2163d6f1-8ced-4c37-9df7-3d4f7d627e72", "node_type": "1", "metadata": {}, "hash": "e36e241dba7c6fe55de73f91f2ce3eaaac2a9e5d16e60a6e3665689adcf556e9", "class_name": "RelatedNodeInfo"}}, "text": "Moxalactam should not be used alone as the \ninitial therapy of meningitis in children because of its \nrelatively poor activity against S. pneumoniae. Aqueous \npenicillin G or ampicillin should be administered with \nmoxalactam until the cause of the meningitis has been \nproved to be H. infl,tenzae type b. \nWe continue to recommend ampicillin for the treatment \nof infections caused by ampicillin-susceptible HIB. Moxa- \nlactam should be considered a drug of choice for the \ntreatment of meningitis caused by HIB resistant to both \nampicillin and chloramphenicol.", "start_char_idx": 328, "end_char_idx": 891, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2163d6f1-8ced-4c37-9df7-3d4f7d627e72": {"__data__": {"id_": "2163d6f1-8ced-4c37-9df7-3d4f7d627e72", "embedding": null, "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3912338c-7bfe-4182-b003-f8473c2f2a85", "node_type": "4", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "842d81a39966dc9bac383c7e6a2226ef7bdc3001279b796df62f1e2072e91e73", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "404bd5dd-4f3a-41f8-9d7a-ca0352f47cff", "node_type": "1", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "c91dad695c6b17776b6ff34cdcfd48dfc1aca640e0bfbb4388859646ca751d37", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "599f1eae-1f3f-4a0b-9bd7-597c74c5119c", "node_type": "1", "metadata": {}, "hash": "3e33e164f2a7d5c75670d6eb92d77b77fd25fd383370c96575ff9b146469adec", "class_name": "RelatedNodeInfo"}}, "text": "Moxa- \nlactam should be considered a drug of choice for the \ntreatment of meningitis caused by HIB resistant to both \nampicillin and chloramphenicol. Cefotaxime and ceftri- \naxone are two other cephalosporins that appear to be \npromising agents for the treatment of HIB meningitis. 2~ A \nmore difficult question is the role of moxalactam and the \nother newer antibiotics in treating infections caused by \nampicillin-resistant HIB. The known risks of chloram- \nphenicol as well as the recommendations to monitor serum \nlevels are disadvantages to its use.", "start_char_idx": 742, "end_char_idx": 1296, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "599f1eae-1f3f-4a0b-9bd7-597c74c5119c": {"__data__": {"id_": "599f1eae-1f3f-4a0b-9bd7-597c74c5119c", "embedding": null, "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3912338c-7bfe-4182-b003-f8473c2f2a85", "node_type": "4", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "842d81a39966dc9bac383c7e6a2226ef7bdc3001279b796df62f1e2072e91e73", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2163d6f1-8ced-4c37-9df7-3d4f7d627e72", "node_type": "1", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "adeebb14662b13b6a1cc198b99b2bd6c35e04c961e6ad3b7695e31cfe322f825", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3e7e5606-daf7-4b33-b882-064069d55310", "node_type": "1", "metadata": {}, "hash": "b30c542ae4e372e39f7a540994f83f7ad0f23174823e1d95576bc6355218b1ec", "class_name": "RelatedNodeInfo"}}, "text": "The known risks of chloram- \nphenicol as well as the recommendations to monitor serum \nlevels are disadvantages to its use. 24'25 On the other hand, \nchloramphenicol has been used safely for many years in \nthe treatment of HIB meningitis, can be administered \norally, and costs less than moxalactam? 5 On the basis of \navailable data, we believe that moxalactam is equivalent to \nchloramphenicol in the therapy of meningitis caused by \nampicillin-resistant HIB in children. \nADDENDUM \nSince acceptance of this article, an additional six chil- \ndren (three ampicillin resistant) have been given moxalac- \ntam; four, ampicillin; and one, chloramphenicol.", "start_char_idx": 1173, "end_char_idx": 1825, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3e7e5606-daf7-4b33-b882-064069d55310": {"__data__": {"id_": "3e7e5606-daf7-4b33-b882-064069d55310", "embedding": null, "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3912338c-7bfe-4182-b003-f8473c2f2a85", "node_type": "4", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "842d81a39966dc9bac383c7e6a2226ef7bdc3001279b796df62f1e2072e91e73", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "599f1eae-1f3f-4a0b-9bd7-597c74c5119c", "node_type": "1", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "932171ca1d49894e826063f7dca1721992b3c2ae76d3206ed0989f47fdc94bc3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "29513cc1-75b6-4d7f-a799-adfe1ae3a184", "node_type": "1", "metadata": {}, "hash": "aac574eff098dce5c1e9131df53540a604a99bd711c05f28a55d1910b52e01fa", "class_name": "RelatedNodeInfo"}}, "text": "Clinical \ncharacteristics, hospital course, and outcome in these \nchildren were the same as reported above. \nWe thank Elaine Calaway, R.N., the Baylor Pediatric 1louse- \nstaff, the private physicians, and the personnel in the Microbiolo- \ngy Laboratory at Texas Children's Hospital, without whose help \nand cooperation this study could not have been performed; Linda \nLamberth and Gall Johnson for technical assistance; and Debbie \nYerian and Marie Mason for help in preparing the manuscript. \nREFERENCES \n1. Schlech WF, Band JD, Hightower AW, Broome CV: Bacte- \nrial meningitis in the United States.", "start_char_idx": 1826, "end_char_idx": 2426, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "29513cc1-75b6-4d7f-a799-adfe1ae3a184": {"__data__": {"id_": "29513cc1-75b6-4d7f-a799-adfe1ae3a184", "embedding": null, "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3912338c-7bfe-4182-b003-f8473c2f2a85", "node_type": "4", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "842d81a39966dc9bac383c7e6a2226ef7bdc3001279b796df62f1e2072e91e73", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3e7e5606-daf7-4b33-b882-064069d55310", "node_type": "1", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "ca2608cd19132647333d62bf507698f5527d06faf567a931b9aa91e7a5cd8458", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ce35d324-3fb3-4754-9e1a-393c0cb9e598", "node_type": "1", "metadata": {}, "hash": "330a3266dfadb482097da59a66e2df320549f6a4c5832e12aa41fcfd667328a6", "class_name": "RelatedNodeInfo"}}, "text": "REFERENCES \n1. Schlech WF, Band JD, Hightower AW, Broome CV: Bacte- \nrial meningitis in the United States. Abstract 31 i, Abstracts \nof the 22nd Interscience Conference on Antimicrobial Agents \nand Chemotherapy, Miami, 1982, American Society for \nMicrobiology. \n2. Roberts MC, Swenson CD, Owens LM, Smith AL: Charac- \nterization of chloramphenicol-resistant ttaemophilus il~uen- \nzae. Antimicrob Agents Chemother 18:610, 1980. 3.", "start_char_idx": 2320, "end_char_idx": 2749, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ce35d324-3fb3-4754-9e1a-393c0cb9e598": {"__data__": {"id_": "ce35d324-3fb3-4754-9e1a-393c0cb9e598", "embedding": null, "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3912338c-7bfe-4182-b003-f8473c2f2a85", "node_type": "4", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "842d81a39966dc9bac383c7e6a2226ef7bdc3001279b796df62f1e2072e91e73", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "29513cc1-75b6-4d7f-a799-adfe1ae3a184", "node_type": "1", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "14afff071e5af24bdd9195e6b42c709fff817aa0eab9b899c74f3734735eb860", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "109d7ca1-ca8c-4723-97e3-2a22adc25609", "node_type": "1", "metadata": {}, "hash": "6b8811df45adbc6f6172e89d8b5b7a7a5fdc2d8804be5513899cb4116ccf7201", "class_name": "RelatedNodeInfo"}}, "text": "Antimicrob Agents Chemother 18:610, 1980. 3. Kenny JF, Isburg CD, Miehaels RII: Meningitis due to \ntlaemophilus influenzae type b resistant to both ampicillin \nand chloramphenicol. Pediatrics 66:14, 1980. \n4. Uchiyama N, Greene GR, Kitts DI3, Thrupp LD: Meningitis \ndue to Haemophilus influenzae type b resistant to ampicillin \nand chloramphenicol. J PF.OI,vrR 97:421, 1980. \n5.", "start_char_idx": 2705, "end_char_idx": 3083, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "109d7ca1-ca8c-4723-97e3-2a22adc25609": {"__data__": {"id_": "109d7ca1-ca8c-4723-97e3-2a22adc25609", "embedding": null, "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3912338c-7bfe-4182-b003-f8473c2f2a85", "node_type": "4", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "842d81a39966dc9bac383c7e6a2226ef7bdc3001279b796df62f1e2072e91e73", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ce35d324-3fb3-4754-9e1a-393c0cb9e598", "node_type": "1", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "e5cc81ca1449630a76ac6d8e99750b1d819db0fd6f409ee0da7e252f5c8089bd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "476c4ccf-ab5b-4360-aa16-57090bfd2fae", "node_type": "1", "metadata": {}, "hash": "d5888475ca766e7d093cab97d70283e6945002db55bd734ddd0bff90e1d5c1b9", "class_name": "RelatedNodeInfo"}}, "text": "J PF.OI,vrR 97:421, 1980. \n5. Mason EO, Kaplan SL, Anderson DC, Hinds DB, Feigin RD: \nIn vitro susceptibility of 104 clinical isolates of ttaemophilus \ninfluenzae to moxalactam (LY 127935), ampicillin, chloram- \nphenicol, and ticarcillin. Antimicrob Agents Chemother \n17:470, 1980. \n6. l.andesman SH, Corrado NIL, Cherubin CC, Gombert M, \nCleri D: Diffusion of a new beta-lactam (LY 127935) into \ncerebrospinal fluid: Implications of therapy for gram-negative \nbacillary meningitis.", "start_char_idx": 3054, "end_char_idx": 3536, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "476c4ccf-ab5b-4360-aa16-57090bfd2fae": {"__data__": {"id_": "476c4ccf-ab5b-4360-aa16-57090bfd2fae", "embedding": null, "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3912338c-7bfe-4182-b003-f8473c2f2a85", "node_type": "4", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "842d81a39966dc9bac383c7e6a2226ef7bdc3001279b796df62f1e2072e91e73", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "109d7ca1-ca8c-4723-97e3-2a22adc25609", "node_type": "1", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "4aefb09bad423046c467de5711bbb60bc3be2de990661db00f3da3bd14672937", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "68c6d0d0-321a-47cd-b116-d6e9bb7f2099", "node_type": "1", "metadata": {}, "hash": "7df160d90f7381032f1f5a7b3734128f6e0ee87dbdac566c678a8e92da88c569", "class_name": "RelatedNodeInfo"}}, "text": "Am J Med 69:92, 1980. \n7. Kaplan SL, Mason EO, Garcia ti, Kvernland S J, Loiselle \nEM, Anderson DC, Mintz AA, Feigin RD: Pharmacokinetics \nand cercbrospinal fluid penetration of moxalactam in children \nwith bacterial meningitis. J PEDIATR 98:152, 1981. \n8. Schaad UB, McCracken GH, Threlkeld N, Thomas ML: \nClinical evaluation of a new broad-spectrum oxa-beta-lactam \nantibiotic, moxalactam, in neonates and infants. J PEDIA'rR \n98:129, 1981. \n9.", "start_char_idx": 3537, "end_char_idx": 3983, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "68c6d0d0-321a-47cd-b116-d6e9bb7f2099": {"__data__": {"id_": "68c6d0d0-321a-47cd-b116-d6e9bb7f2099", "embedding": null, "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3912338c-7bfe-4182-b003-f8473c2f2a85", "node_type": "4", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "842d81a39966dc9bac383c7e6a2226ef7bdc3001279b796df62f1e2072e91e73", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "476c4ccf-ab5b-4360-aa16-57090bfd2fae", "node_type": "1", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "2be8cf28dd4c6b014847d3e3cf04f78a0eb2cac03394ffb7f661d6a5f15214df", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a5e7e202-0b81-4407-b386-6bd1103ea194", "node_type": "1", "metadata": {}, "hash": "4daa4a1881cc91294a9ca5aa2b2cf472213d6ea720b5ac73ae602d8b79c09ba0", "class_name": "RelatedNodeInfo"}}, "text": "J PEDIA'rR \n98:129, 1981. \n9. Kaplan SL, Mason EO, Kvernland S J, Loiselle EM, Feigin \nRD: Moxalactam treatment of serious infections primarily \ndue to Haemophilus influenzae type b in children. Pediatrics \n71:187, 1983. \nI0. Feigin RD, Stechenberg BW, Chang M J, Dunkle LM, Wong \nML, Palkes H, Dodge PR, Davis H: Prospective evaluation of \ntreatment of ttemophilus influenzae meningitis. J PEDIATR \n88:542, 1976. \n11.", "start_char_idx": 3954, "end_char_idx": 4372, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a5e7e202-0b81-4407-b386-6bd1103ea194": {"__data__": {"id_": "a5e7e202-0b81-4407-b386-6bd1103ea194", "embedding": null, "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3912338c-7bfe-4182-b003-f8473c2f2a85", "node_type": "4", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "842d81a39966dc9bac383c7e6a2226ef7bdc3001279b796df62f1e2072e91e73", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "68c6d0d0-321a-47cd-b116-d6e9bb7f2099", "node_type": "1", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "9725f022fdf5d7f5881c7733a6f463bf36e4522aac1f39fed2b15b83adee337c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0ae7646f-cd8d-46a1-ba06-97484cab2906", "node_type": "1", "metadata": {}, "hash": "e5cbe6290aa3c2d5a1d5686e5e700171fbf2a7f9df980158b9a70ed51ffcf4cb", "class_name": "RelatedNodeInfo"}}, "text": "J PEDIATR \n88:542, 1976. \n11. Escamilla J: Susceptibility of Haemophilus influenzae to \nampicillin as determined by use of a modified, one-minute \n/~-lactamase test. Antimicrob Agents Chemother 9:i96, \n1976. \n12. Mason EO, Kaplan SL, Lamberth LB, Ilinds DB, Kvernland \nS J, Loiselle EM, Feigin RD: Serotype and ampicillin suscep- \ntibility of ttaentophilus it~htenzae causing systemic infec- \ntions in children: Three )'ears' experience. J Clin Microbiol \n15:543, 1982. \n13.", "start_char_idx": 4343, "end_char_idx": 4817, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0ae7646f-cd8d-46a1-ba06-97484cab2906": {"__data__": {"id_": "0ae7646f-cd8d-46a1-ba06-97484cab2906", "embedding": null, "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3912338c-7bfe-4182-b003-f8473c2f2a85", "node_type": "4", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "842d81a39966dc9bac383c7e6a2226ef7bdc3001279b796df62f1e2072e91e73", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a5e7e202-0b81-4407-b386-6bd1103ea194", "node_type": "1", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "0e4d72fc82be473392b950aca6a49c13aeb0b121e2558c0e704337dd4517bb24", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8d5243d6-4bc1-4fb3-a94b-85d8bbb0151b", "node_type": "1", "metadata": {}, "hash": "c9d3962e61ce910ef15ce2290bbd9c899488699ab0f1ae1d04b936fb985cfa10", "class_name": "RelatedNodeInfo"}}, "text": "J Clin Microbiol \n15:543, 1982. \n13. Keyserling II, Feldman WE, Mofiitt S, Manning N, Hollins \nM: Clinical and pharmacokinetic evaluation of parenteral \nmoxalactam in infants and children. Antimicrob Agents \nChemother 21:898, 1982. \n14. Romagnoli MF, Flynn K, Siber GR, Goldmann DA: Moxa- \nlactam pharmaeokinetics in children. Antimicrob Agents \nChemother 22:47, 1982. \n15.", "start_char_idx": 4781, "end_char_idx": 5154, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8d5243d6-4bc1-4fb3-a94b-85d8bbb0151b": {"__data__": {"id_": "8d5243d6-4bc1-4fb3-a94b-85d8bbb0151b", "embedding": null, "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3912338c-7bfe-4182-b003-f8473c2f2a85", "node_type": "4", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "842d81a39966dc9bac383c7e6a2226ef7bdc3001279b796df62f1e2072e91e73", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0ae7646f-cd8d-46a1-ba06-97484cab2906", "node_type": "1", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "37439ce32dd122e859a1613d18a2157b4c67dd02fc5d49f8f92d4cdefac68078", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c1440b50-82c9-45c0-a93a-1720f15f3e4d", "node_type": "1", "metadata": {}, "hash": "c9c05ab9d89d5d584460c3b9b8c4e5aef5a635b4ad658c42e82931a295f02da5", "class_name": "RelatedNodeInfo"}}, "text": "Antimicrob Agents \nChemother 22:47, 1982. \n15. Latif R, Thirumoorthi MC, Buckley JA, Kobos DM, Aravind \nMK, Kauffman RE, Dajani AS: Pharmacokinetic and clinical \nevaluation of moxalactam in infants and children. Dev Phar- \nmacol Ther 3:222, 1981. \n16. Yogev R, Schreiber M, Gardner S, Shulman ST: Moxalac- \ntam in the treatment of pediatric infections. Am J Dis Child \n136:836, 1982. \n17.", "start_char_idx": 5108, "end_char_idx": 5496, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c1440b50-82c9-45c0-a93a-1720f15f3e4d": {"__data__": {"id_": "c1440b50-82c9-45c0-a93a-1720f15f3e4d", "embedding": null, "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3912338c-7bfe-4182-b003-f8473c2f2a85", "node_type": "4", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "842d81a39966dc9bac383c7e6a2226ef7bdc3001279b796df62f1e2072e91e73", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8d5243d6-4bc1-4fb3-a94b-85d8bbb0151b", "node_type": "1", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "907d342c621d12b1d44b6ef15cfe31cefafb99f44c3868b50bc29d909fa9e1df", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5c8cbb78-2042-465c-a1cf-81e82ab1a66b", "node_type": "1", "metadata": {}, "hash": "4d1eab8c6a9f277e191d32105ad638dec2b27d2bb375c3b8c158045a36db6858", "class_name": "RelatedNodeInfo"}}, "text": "Yogev R, Schreiber M, Gardner S, Shulman ST: Moxalac- \ntam in the treatment of pediatric infections. Am J Dis Child \n136:836, 1982. \n17. Olson DA, Hoeprich PD, Nolan SM, Goldstein E: Successful \ntreatment of gram-negative bacillary metiingitis with moxa- \nlactam. Ann Intern Med 95:302, 1981. \n18. Rahal J J: Moxalactam therapy for gram-negative bacillary \nmeningitis. Rev Infect Dis 4:$606, 1982. \n19. Hoffman SIi, Freedman J, Rocha tl, Lynch MA, Scheld \nWNI, Sande MA: Therapy of meningitis in children with", "start_char_idx": 5360, "end_char_idx": 5869, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5c8cbb78-2042-465c-a1cf-81e82ab1a66b": {"__data__": {"id_": "5c8cbb78-2042-465c-a1cf-81e82ab1a66b", "embedding": null, "metadata": {"page_label": "7", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "1d790fc5-cbe7-43bf-86be-154656ecfdd0", "node_type": "4", "metadata": {"page_label": "7", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "f322594c097aecf851a7aff72c424496469c20218f926085bb1dce907fb04bbe", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c1440b50-82c9-45c0-a93a-1720f15f3e4d", "node_type": "1", "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "a4eef29da8339997ef3383f74fbd204c93147ae506fd518d804c023e3e4b014e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5c9ed7c6-da9b-4d16-b4be-dd46988a622d", "node_type": "1", "metadata": {}, "hash": "17918cf93ce52c1f401377881d6722b6138dec62d37c972b5e4194de9be37942", "class_name": "RelatedNodeInfo"}}, "text": "Volume 104 Moxalactam treatment of H. influenzae type b meningitis 4 5 3 \nNumber 3 \nmoxalactam. Abstract 315, Abstracts of the 22nd Inter- \nscience Conference on Antimicrobial Agents and Chemother- \napy, Miami, 1982, American Society for Microbiology. \n20. Feigin RD, Kaplan SL: Bacterial meningitis. In Appel SH, \neditor: Current neurology. New York, 1981, John Wiley, pp \n255-279. \n21. Bang NU, Tcssler SS, Heidenreich RO, Marks CA, Mattler \nLE: Effects of moxalactam on blood coagulation and platelet \nfunction. Rev Infect Dis 4:$546, 1982.", "start_char_idx": 0, "end_char_idx": 543, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5c9ed7c6-da9b-4d16-b4be-dd46988a622d": {"__data__": {"id_": "5c9ed7c6-da9b-4d16-b4be-dd46988a622d", "embedding": null, "metadata": {"page_label": "7", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "1d790fc5-cbe7-43bf-86be-154656ecfdd0", "node_type": "4", "metadata": {"page_label": "7", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "f322594c097aecf851a7aff72c424496469c20218f926085bb1dce907fb04bbe", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5c8cbb78-2042-465c-a1cf-81e82ab1a66b", "node_type": "1", "metadata": {"page_label": "7", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "8cc562f39cd9a5886aa1464cba77f483f11025cb0191e0394f20ba5df4987f15", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fed5c235-73aa-4421-8572-55071b4740a0", "node_type": "1", "metadata": {}, "hash": "586bca3a04be15c7847646bc9abfdbe663f179ad6e30be01df5d6baa27ff18ce", "class_name": "RelatedNodeInfo"}}, "text": "Rev Infect Dis 4:$546, 1982. \n22. Weitekamp MR, Aber RC: Prolonged bleeding times and \nbleeding diathesis associated with moxalactam administra- \ntion. JAMA 249:69, 1983. 23. Del Rio MDL, Chrane D, Skelton S, McCracken GH Jr, \nNelson JD: Ceftriaxone versus ampicillin and chlorampheni- \ncol for treatment of bacterial meningitis in children. Lancet \n1:1241, 1983. \n24. Oski FA: Hematologic consequences of chloramphenicol \ntherapy. J PEDIATR 94:515, 1979. \n25.", "start_char_idx": 515, "end_char_idx": 975, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fed5c235-73aa-4421-8572-55071b4740a0": {"__data__": {"id_": "fed5c235-73aa-4421-8572-55071b4740a0", "embedding": null, "metadata": {"page_label": "7", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "1d790fc5-cbe7-43bf-86be-154656ecfdd0", "node_type": "4", "metadata": {"page_label": "7", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "f322594c097aecf851a7aff72c424496469c20218f926085bb1dce907fb04bbe", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5c9ed7c6-da9b-4d16-b4be-dd46988a622d", "node_type": "1", "metadata": {"page_label": "7", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}, "hash": "d63592245c30426b4b8445921beaed4ab9be30aeefa3314c8ae0f737ca78a95a", "class_name": "RelatedNodeInfo"}}, "text": "24. Oski FA: Hematologic consequences of chloramphenicol \ntherapy. J PEDIATR 94:515, 1979. \n25. Tuomanen El, Powell KR, Marks MI, [.aferriene CI, AItmil- \nler DIL Sack CM, Smith AL: Oral chloramphenicol in the \ntreatment of Ilaemophilus influenzae meningitis. J PEDIATR \n99:968, 1981.", "start_char_idx": 880, "end_char_idx": 1164, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}}, "docstore/ref_doc_info": {"d863d433-4475-4344-b4ac-5ac34a833ccd": {"node_ids": ["2505f607-76f0-4004-8664-416ab7fb3d81", "6e366ac5-3820-4023-a3b3-aee173a5b55c", "b120fde4-fa4f-4c97-af04-9fde0fb3029e", "2f6ea9d5-0962-45c2-be7e-4881854399e7", "d5635ba9-db72-4c20-b5f1-824b6d9e30c4", "f2600675-2532-4c69-9b9b-9c26cf11d7b4", "8622325b-3b85-44ae-b3c3-d19486fd274b"], "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}}, "aba4136e-5beb-4831-9277-1f1b51256d0b": {"node_ids": ["b0695074-4415-46d5-84c3-dcb05ef29450", "4295b39f-da86-44b8-8706-535df9e144ec", "86d9261a-1a83-4d8b-a789-8a20946a14e1", "cc9d669f-c47b-4262-ba30-9ada3e4dd36f", "099c6047-9593-4c6d-a8b8-8cdaf39dfb5e", "84761669-4bc7-43e7-9437-cec149f174f4", "f3f06a58-5cd3-4e27-a2de-3ddd2271cdb2", "e47539c1-5d52-41f9-a080-87dc906ae48c", "1c2c7974-211c-4589-9eb0-0d127d403dfd"], "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}}, "5d5d60e5-7647-43b4-a9b9-c8b07b310041": {"node_ids": ["110a19ca-a76e-4592-9f8c-1c67d9f59b6f", "26fcb611-28f0-4c25-96a4-9b7c996e19f6", "3b96abaa-2b8c-4b15-90c9-084c6f9a0349", "2debd2bb-cf88-4ec6-b474-b80bf2e51b68", "f4e4bcfd-bff0-4631-b96a-da8d95688275", "6b9cd269-5e33-4c9b-8931-caf3f76b1f52", "860d1f00-25d1-4acb-b7c1-f5f6f880562e", "294390df-0ea7-40aa-936c-717e6d1ff2b9", "45530c7f-a444-43f8-b4c9-21184fd315d5", "1404f48b-f50c-4e2c-87b3-bd7e8ec8f3ab"], "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}}, "9d32d9f7-2ed4-481c-a26f-a82e98d4ace0": {"node_ids": ["ed749120-b03f-46b2-b747-55f47aaac973", "8e86ca9e-3616-4894-85cc-25e31416452a", "15859d1f-cf7e-42f7-a393-c4df7088ff4c", "a14a78f8-9f82-42dd-88ee-65b6feca9b87", "64bd04da-df4c-4973-94cd-c7fcaeedb714", "69f8d83e-18b3-4607-8420-f11c9e6f697b", "520dfa32-0f3a-4110-a50c-f282d9cc1c23", "59eb8509-419c-48ea-ac83-2cc819e8df25", "23bb07db-3dc6-44fe-ba08-7f280da80532", "a35ab5ca-cb22-4893-87e6-9ceaf1a21ef0", "46fdc0f7-bbda-4ee5-bdb9-f0dd2e4fef86", "cc893d8c-ea56-4c2e-bfd7-44163d19a56f"], "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}}, "ea199b63-3470-44b2-ac1a-0efb10f163e0": {"node_ids": ["d84b3478-90f6-473a-ba87-d79c2c6d1f28", "da72eb85-5958-4c85-bb21-003423e68378", "8a78a7de-fc0e-46e5-bc3c-26a619c700a1", "a32bb617-616d-4900-bc75-90ce1ff77546", "46381ef6-bf54-4f70-b983-21cd466c021f", "ac84563f-2d04-4318-8d04-08658385cefc", "2e4a3692-d6d6-4d4e-80ea-7761ab80756e", "46bb668f-3a1f-4e5d-b6ad-6be40de3b4f1", "048546fa-55b9-43b2-ba78-cb525e86a123", "e434d935-f7b1-477e-aaa4-c3e3ec17e050"], "metadata": {"page_label": "5", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}}, "3912338c-7bfe-4182-b003-f8473c2f2a85": {"node_ids": ["6320e6a3-0d3b-46f8-b318-3d2e11911304", "404bd5dd-4f3a-41f8-9d7a-ca0352f47cff", "2163d6f1-8ced-4c37-9df7-3d4f7d627e72", "599f1eae-1f3f-4a0b-9bd7-597c74c5119c", "3e7e5606-daf7-4b33-b882-064069d55310", "29513cc1-75b6-4d7f-a799-adfe1ae3a184", "ce35d324-3fb3-4754-9e1a-393c0cb9e598", "109d7ca1-ca8c-4723-97e3-2a22adc25609", "476c4ccf-ab5b-4360-aa16-57090bfd2fae", "68c6d0d0-321a-47cd-b116-d6e9bb7f2099", "a5e7e202-0b81-4407-b386-6bd1103ea194", "0ae7646f-cd8d-46a1-ba06-97484cab2906", "8d5243d6-4bc1-4fb3-a94b-85d8bbb0151b", "c1440b50-82c9-45c0-a93a-1720f15f3e4d"], "metadata": {"page_label": "6", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}}, "1d790fc5-cbe7-43bf-86be-154656ecfdd0": {"node_ids": ["5c8cbb78-2042-465c-a1cf-81e82ab1a66b", "5c9ed7c6-da9b-4d16-b4be-dd46988a622d", "fed5c235-73aa-4421-8572-55071b4740a0"], "metadata": {"page_label": "7", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/6368777/6368777.pdf", "file_path": "documents\\6368777\\6368777.pdf", "file_type": "application/pdf", "file_size": 507181, "creation_date": "2024-04-11", "last_modified_date": "2024-04-11"}}}}